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COUNTER-REGULATION OF ILEAL MOTILITY IN RABBIT SMALL
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Ferzoco. Department of Surgery,

University School of Medicine,

New Haven,

Yale

CT.

Disorders of intestinal motility continue to plague
surgeons of the twentieth century.

Unfortunately,

the

regulation of intestinal motility remains incompletely
understood.
system,

Utilizing the isolated whole organ perfusion

segments of rabbit terminal ileum were infused with

variety of known gastrointestinal hormones,
neurotransmitters.

In the first series of experiments,

prokinetic agents such as carbachol
analogue),

peptides and

cholecystokinin,

(an acetylcholine

motilin and were tested.

All

three agents caused a concentration-dependent increase in
measured motor activity.
experiments,
cAMP,

In the second series of

agents which increase intracellular levels of

vasoactive intestinal peptide

norepinephrine,

All three agents caused a concentration-

dependent inhibition of motility.
neuropeptide Y

(NPY)

In the third series of
and peptide YY

agents which block intracellular cAMP,
inhibitory action of VIP.
experiments,

forskolin and

were tested against prokinetic-stimulated

segments of ileum.

experiments,

(VIP),

(PYY),

reversed the

In the final series of

various NPY/PYY analogues with specific Y

receptor affinity were tested.

The Yx receptor analogue

.
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FERZOCO,
[Leu31,

SJ

3

-

-

Pro34]NPY demonstrated similar ability to reverse

VIP's effect.

In conclusion,

two distinct phases.

peristalsis can be divided into

Ascending contraction caused by

prokinetic agents is orad to a food bolus.

In addition, VIP

is responsible for the descending inhibitory reflex distally.
NPY released within neurons within the gut wall causes
reversal of the VIP-mediated inhibition leading to a wave of
ascending contraction.
receptor mechanism.

This reversal is mediated via a Yl
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BACKGROUND

20th Century man is afflicted with the ravages of many
newly-recognized diseases.

Many of these are based on

motility disorders of the gut.

Indeed,

syndrome,

constipation and perhaps even

diverticular disease,

the irritable bowel

the genesis of gastrointestinal malignancy can be traced to
pertubations of normal intestinal peristalsis.
Consequently,

exploration of regulatory systems which

modulate small bowel and colon motility may lead to new
therapeutic modalities for diseases of 20th century man.
Indeed,
Greek,

this approach was the basis of classical medicine.
Roman and medieval medicine realized the importance in

restoring normal intestinal motility in various states of
disease.

Ancient physicians utilized a variety of cathartics

and clysters to purge disease from the intestines and
regulate motility.
In this thesis I have focused on the small bowel.

Small

bowel motility has been studied extensively in vivo but this
has not allowed identification of specific regulatory
systems.

Examination of gut motility in an in vitro system

eliminates exogenous neural and humoral influences and
facilitates characterization of specific mechanisms.

It is

the identification of the intrinsic mechansism of the gut
which will lead to new avenues of therapeutic intervention in
diseases such as irritable bowel syndrome.

*
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HYPOTHESIS

The regulation of intestinal motility remains
incompletely understood.

Peristalsis can be best defined as

alternating zones of high and low pressure which sweep food
down the intestines.

Proximal to a food bolus,

prokinetic

agents cause smooth muscle contraction leading to generation
of a high pressure zone.

This high pressure zone is

responsible for ascending contraction.

Distally,

it is

postulated that vasoactive intestinal peptide mediates the
descending inhibitory reflex.
zone,
zones.

or transition zone,

In addition there is a third

between the high and low pressure

We hypothesized that there must exist some counter-

regulatory agent which reverses the descending inhibitory
reflex caused by vasoactive intestinal peptide and allow the
generation of the high pressure zone by prokinetic agents.
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OF

THE

SPECIFIC

AIMS

The specific aims of the study were:
1.

to test the effects of various prokinetic agents on

isolated segments of rabbit terminal ileum.
2.

to test the effects of agents which increase

intracellular cAMP levels on stimulated segments of ileum.
3.

to demonstrate the effects of agents which inhibit cAMP

accumulation on vasoactive intestinal peptide-mediated
inhibition of motility.
4.

to demonstrate the effects of various NPY receptor

analogues on VIP-mediated inhibition of motility.
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HISTORICAL BACKGROUND
Thfi Role of Gut Motility Modulation
in Classical Medical Therapy

Classical physicians based their treatment of disease
upon concepts of physiology and pathology which were quite
different than current concepts.

Consequently,

their

approach to therapeutics seems alien to the modern practice
of medicine.

These views,

however,

persisted well into the

19th Century and many still survive among folk remedies for
various conditions.

Whereas modern therapeutics is based

upon experimental science,

classical practice was founded

upon millenia of careful and meticulous observation.
result,

As a

medical writings from previous centuries offer an

immense wealth of clinical observations on the natural
history of diseases.

In addition,

modern therapeutics is

based on pharmacology while in classical therapeutics the
physician attempted to guide and support their patients
through illnessess by alterations of diet,

bloodletting,

and

stimulation of changes in bowel function and urination.
The gastrointestinal tract played a prominent role in
the therapeutics of classical medicine.

The classical

physician believed that the maintenance of normal bowel
function was a prerequisite for continued good health

(Celsus

FERZOCO,
1979).
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He considered that alterations of bowel function

played a role in the genesis of some diseases.

Moreover,

the

classical physician used manipulation of gastrointestinal
motility as one of their primary modalities for the treatment
of both acute and chronic diseases.
The definition of disease was quite different for the
classical physician than that which is generally accepted at
the present time.

As a result,

the goals of classical

therapeutics were entirely disparate from those of modern
medical practice.

In this section,

we will review the

classical definition of disease and then examine how this
definition led to the use of emetics,

cathartics,

clysters,

purgatives and enemas in the treatment of acute and chronic
illnesses by physicians until relatively recent times.

The Definition of Disease.
The approach of classical physicians to disease evolved
from their assumptions of the economy of the human body and
the genesis of disease.

The role of the physician and his

choice of therapies derived from these postulates.
Hippocrates describes the development of medical practice in
Ancient Medicine.

The role of diet in health and in disease

was evidently always a central concern of the physician.
Hippocrates writes:
"For the art of Medicine would not have been
invented at first, nor would it have been made a subject
of investigation (for their would have been no need of

1

4
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it,) if when men are indisposed, the same food and other
articles of regimen which they eat and drink when in
good health were proper for them, and if others were
preferable to these.
But now necessity itself made
medicine to be sought out and discovered by men, since
the same things when administered to the sick, which
agreed with them in good health, neither did nor do
agree with them (Hippocrates)."
Hippocrates indicated that the earliest role of the physician
was the study of diet in health and disease and that
therapeutics was initially based on changes in diet.
Furthermore,

Hippocrates stressed that the natural faculties

functioned differently in health and in disease.

We will

return to this issue in the next section.
The teachings of Hippocrates remained a central theme in
Western medicine until recent times.

Thomas Sydenham,

leading practioner of medicine in the 17th Century,
for a greater return to these Hippocratic ideals.

the

pleaded
A distinct

definition of classical concepts of disease is offered by
Thomas Sydenham in his Medical Observations Concerning the
History and Cure of Acute Diseases:
"A disease, however much its cause may be adverse
to the human body, is nothing more than an effort of
Nature, who strives with might and main to restore the
health of the patient by the elimination of the morbific
matter. For, since it is the will of God, the Supreme
Arbiter and Regulator of all things, that the human
frame be, by nature adapted to the reception of
impressions from without, it follows that it must also
be liable to a variety of maladies.
These arise partly
from the particles of the atmosphere, partly from the
different fermentations and putrefactions of the
humours.
The first insinuate themselves amongst the
juices of the body, disagree with them, mix themselves
up with the blood; and, finally, taint the whole frame
with the contagion of disease.
The second are confined
within the body longer than they ought to be, its powers

»£fl

'
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having proved incompetent, first to their digestion,
afterwards to their excretion.
This may arise from
either their bulk, or the incongruity of their qualities
(Sydenham 1847)."

The contrast of this definition to modern concepts was
pointed out by Benjamin Rush in his introduction to an
American Edition of The Works of Thomas Svdenham, M.D,
published early in the 19th Century

(Sydenham 1809).

Rush

wrote:
"I consider our author's (Thomas Sydenham)
definition of a disease to be erroneous, viz. that it is
'a vigorous effort of nature to throw off morbific
matter, and thus to recover the patient,' instead of
which I believe a disease, to use the definition he has
rejected, to consist 'in the confused and irregular
operations of disordered and debilitated nature'.
(Sydenham 1809, p. iv)
This contrast of views in the cause of symptoms is central to
the differences between the classical practice of medicine
and current therapeutics.

For the classical physician,

the

symptoms of disease were the response of the patient's
constitution to an illness and thus,
be promoted.

something which should

In sharp contrast, modern physicians tend to

think of symptoms as the consequence of disease and that
suppression of the symptoms will ameliorate the disease.
Sydenham's definition highlights two fundamental
postulates of classical medicine.

The first is the belief

that the symptoms of disease are produced by the response of
the natural faculties to the disease.

The second is that the

genesis of disease is through the putrefaction of humors

FERZOCO,
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within the body.

Both of these points must be grasped to

appreciate the use of prokinetic agents in the treatment of
disease.

Vis Medicatrix Naturae
The classical physician studied attentively the
progression of symptoms in acute and chronic illnesses.
particular,

In

he focused on the divergence of symptoms between

patients that recovered and those that succumbed from the
disease.

It was the role of the physician to promote

symptoms such as vomiting and diarrhea when the response of
the patient was judged inadequate and to temper symptoms when
they became too extreme.

This approach to therapeutics

derived from the concept that symptoms were the response of
the patient's constitution to the illness and represented the
attempts of the patient’s body to throw off the irritating
causes of his illness.

The role of the physician,

to assits nature in the fight against disease

then,

was

(Guthrie 1946,

Kutumbiah 1971).
The importance of Nature in the battle against disease
explicitly remained the central postulate of therapeutics
until the 19th Century.
Medicatrix Naturae.

This doctrine was deemed Vis

William Cullen,

Professor of Medicine

at the University of Edinburgh in the late 18th and early
19th Century,

defined this important concept.

while addressing the Phaenomena of Fevers:

Cullen wrote

.

"
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"How the state of debility produces some of the
symptoms of the cold stage, we cannot particularly
explain, but refer it to a general law of the animal
oeconomy, whereby it happens, that powers, which have a
tendency to hurt and destroy the system, often excite
such motions as are suited to obviate the effects of the
noxious power.
This is the VIS MEDICATRIX NATURAE, so
famous in the school of physic; and it is probable, that
many of the motions excited in fever are the effects of
this power (Cullen 1777)."
Thus,

the classical physician did not believe that he could

directly treat a disease.

Instead,

his role was to support

and to assist the natural response of his patient to his
illness.

The physician guided the powers of nature in the

struggle against disease.

Classical

Concepts

of

Digestion.

Classical physicians were forbidden to dissect the human
body because of prevalent religious doctrines regarding the
sanctity of man.
was limited.

Consequently,

Similarly,

only be inferred.
economy developed.

knowledge of human anatomy

the function of various organs could

Nonetheless,

concepts of the animal

In order to understand the goals of

physicians in the use of cathartics and purgatives in the
treatment of disease a brief description of classical
concepts of digestion is required.
Classical concepts of digestive physiology and on the
functions of the intestine have descended to us primarily
through the writings of Galen.

Classical perception of

digestion is outlined in On The Natural Faculties

(Galen

FERZOCO,
1927).
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The Natural Faculty of Digestion was accomplished by

Presentation

(prosthesis)

alimentary tract,
to the wall of

2.

of

Adhesion

the organs,

3.

the nutrients

(prosphysis)

of the nutrients

Assimilation

(alteration)

the nutrients into the lacteals and vessels,
the nutrients until assimilation occurred,
of the unabsorbed substances

to the

4.

Retention of

and 5.

(superfluidities) .

of

Expulsion

All

discourses on digestion adhered to this general theory for
the next fifteen centuries.

It must be emphasized,

however,

that these processes were not confined to the
gastrointestinal tract.

Role of Digestion in the Genesis and Treatment of Disease
The natural faculty of nutrition and the processes of
digestion could lead to the generation of disease and could
also be used to treat diseases.

The manner by which

alterations of digestion could lead to disease was descibed
by Sydenham in his discussion On Acute Diseases in General.
Sydenham wrote that diseases

"arise partly from the particles

of the atmosphere, partly from the different fermentations
and putrefactions of the humors

(Sydenham 1847)."

Further,

he detailed the alterations in digestion which caused
illness:
"The (different fermentations and putrefactions of
the humours) are confined within the body longer than
they ought to be, its powers having proved incompetent,
first to their digestion, afterwards to their excretion.

FERZOCO,
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This may arise from either their bulk, or the
incongruity of their qualities (Sydenham 1847)."
Thus,

it was supposed that an accumulation of superfluidities

and putrefactions within the body produced many of the acute
and chronic illnesses.
Fortunately,

Nature had forseen this eventuality and

provided mechanisms for the body to cleanse itself of these
offending substances.

Sydenham again offers a succinct

description of these processes:
"Hence Nature, in the concatenation and exclusion
of the peccant and foreign matter, which otherwise,
would undo the whole fabric of our frame...This
undertaking Nature performs at different rates; quickly
or slowly, according to the different processes by which
she strives to expel the morbid influence...As often she
calls in the aid of fevers for the isolation of the
tainted particles from the remainder of the blood; and
when, by a further process, either by diaphoresis or
diarrhoea, by eruptions, or some other evacuations, she
expels the particles thus isolate (Sydenham 1847)."
Nature fights off these diseases through the elimination of
the offending substances.

One of the principle ways of

cleansing the system is through evacuations of the bowels.
Thus,

manipulation of bowel function became an important

focus of attention for the classical physician.
Unfortunately,

the response of Nature to these imbalances of

the system were inappropriate.
left,

indeed,

little,
1847)."

and,

to herself,

Sydenham points out:

(Nature)

in either case,

may do too much or too

kill the patient

The role of the physician,

"When

then,

(Sydenham

was to observe the

FERZOCO,
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progress of Nature in the elimination of putrefactions and,
if need be,

either to promote or retard this process.

We will now examine more closely the writings of various
medical authorituies over the last several millenia.

We will

focus on their use of the gastrointestinal tract in their
treatment of disease.

Greek Medicine - Hippocrates
Unquestionably,

the foundation of Greek Medicine is

based on the writings of Hippocrates
Hippocrates,
460 B.C.

(Figure 1).

a native of the island of Cos, was born about

Although little is known about the man himself,

he

is said to have been taught medicine by his father and
traveled extensively within the Greek Empire lecturing on
medicine and surgery.

After his death,

his followers

propagated his teaching to new generations of physicians and
established the Library of the Hippocratic School at Cos
(Osier 1921).
Osier wrote that "empiricism,
of facts,

the evidence of senses,

philosophical speculations,
of Hippocratic medicine.

experience,

the collection

the avoidance of

were the distinguishing features

One of the most striking

contributions of Hippocrates is the recognition that diseases
are only part of the processes of nature,
nothing divine or sacred about them."

that there is

Indeed,

Hippocrates

'

'
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based his treatment of disease on the vis medicatrix naturae,
the power of nature

Figure 1:

(Osier 1921).

Reproduction of a fourteenth-century Byzantine
portrait of Hippocrates, courtesy of the
Bibliotheque Nationale, Paris.
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Hippocrates devoted much attention to gut function.

He

carefully observed the quantity and appearance of stool in
health and believed that maintenance of normal defecation was
a fundamental requirement for continued good health.
illness,

In

Hippocrates studied the changes in the quantity and

character of vomitus or stool which was expelled from his
patients.

He believed that this gave him direct information

about the processes of concoction and putrefaction which were
occurring in his patient.

Further,

by following the changes

in the character of the vomitus and stool he could draw
conclusions about the course of the disease in his patient.
If the patient stopped vomiting and the character of the
stool returned to normal,

the patient had passed through the

crisis of the disease and would recover.
hand,

If on the other

the vomitus became feculent and the stool remain filled

with putrefaction or even worse blood,

the patient would

perish.
Hippocrates described the natural course of bowel
movements in his Prognostics:
"The excrement is best which is soft and
consistent, is passed at the hour which was customary to
the patient when is health, in quantity proportionate to
the ingesta; for when the passages are such, the lower
belly is in a healthy state.
But if the discharges be
fluid, it is favorable that they are not accompanied
with a noise, nor are frequent, nor in great quantity;
for the man being oppressed by frequently getting up,
must be deprived of sleep...But in proportion to the
ingesta he should have evacuations twice or thrice a
day, once at night and more copious in the morning, as
is customary with a person in health.
The faeces should
become thicker when the disease is tending to a crisis;

,

,
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they ought to be yellowish and not very fetid.
It is
favorable that round worms be passed with the discharges
when the disease is tending to a crisis.
The belly,
too, through the whole disease, should be soft and
moderately distended; but excrements that are very
watery, or white, or green, or very red, or frothy, are
all bad.
It is also bad when the discharge is small and
viscid, and white, and greenish, and smooth; but still
more deadly appearances are the black, or fatty, or
livid, or verdigris-green, or fetid.
Such as are of
varied characters indicate greater duration of the
complaint, but are no less dangerous; such as those
which resemble scrapings, those which are bilious, those
resembling leeks, and the black; these being sometimes
passed together and sometimes singly (Hippocrates 1849).
Hippocrates realized the importance of the intestines as
an organ of "concoction" or digestion.

It was important that

the bowel perform this function in order that health be
preserved.

Hippocrates argued that it was necessary for

digested material to be expelled by the body.
XXI of Section I,

"Those things which require to be evacuated

should be evacuated, wherever they most tend,
outlets

In Aphorisms

(Hippocrates 1849)."

Otherwise,

by the proper

the accumulation of

the superfluidities would lead to the genesis of disease.
Similarly,

in Aphorisms XXII of Section I,

move such humours as are concocted,
unconcocted,

"We must purge and

not such as are

unless they are struggling to get out,

mostly not the case

(Hippocrates 1849)."

When the use of purgatives is indicated,
to augment them through their natural course.
II of Section IV,

which is

it is necessary
In Aphorisms

"In a purging we should bring away such

matters from the body as it would be advantageous had they
come away spontaneously,

but those of an opposite character

,

FERZOCO,

SJ

GUT MOTILITY IN CLASSICAL THERAPEUTICS -22-

should be stopped

(Hippocrates 1849)." The physician assists

nature in the regulation of digestion.
Hippocrates also used evacuation of the bowels as a
central weapon in his arsenal for the therapy of diseases.
In Aphorisms LXVIII of Section VII,
acute diseases:
and not shaken,
the bowels),

Hippocrates wrote that in

"When the dejections are allowed to stand
and a sediment is formed like scraping

in such a case it is proper to purge the bowels;

(Hippocrates 1849)."

Further,

in the Appendix to the works

On the Regimen in Acute Diseases,

Section XV,

diseases are resolved either by the mouth,
bladder,

or some other such organ.

resolution in all these cases

he adds:

the bowels,

the

(Hippocrates 1849)."

necessary for the elimination of disease,

although

had to be used

In Aphorisms XXIV of Section I,

he states,

purgative medicines sparingly in acute diseases,
commencement,

"All

Sweat is a common form of

Hippocrates felt that the use of purgatives,

judiciously.

(of

"Use

and at the

and not without proper circumspection

(Hippocrates 1849)."
Hippocrates prescribed many regimens in the treatment of
disease.

The majority of them dealt with abnormalities of

the gastrointestinal tract.

The majority of his treatment

modalities can be found in his On Regimen in Acute Diseases:

Section V:
"Ptisans are to be made of the very best
barley, and are to be well boiled, more especially if you
do not intend to use them strained.
For, besides

'

FERZOCO,

SJ

GUT MOTILITY IN CLASSICAL THERAPEUTICS -23-

the other virtues of ptisan, its lubricant quality
prevents the barley that is swallowed from proving
injurious... for that which is well boiled is very
lubricant... of very easy digestion... If then one do not
pay proper attention to the mode of administering the
ptisan, much harm may be done; for when the food is shut
up in the bowels, unless one procure some evacuation
speedily, before administering the draught, the pain, if
present, will be exasperated (Hippocrates 1849).
Section VII;
But if the pain be below the
diaphragm, and do not point to the clavicle, we must
open the belly either with black hellebore or peplium,
mixing the black hellebore with carrot or seseli, or
cumin, or anise, or any of the other fragrant herbs; and
with the peplium the juice of the sulphium
(assafoetida), for these substances when mixed together,
are of similar nature.
The black hellebore acts more
pleasantly and effectually than the peplium, while, on
the other hand, the peplium expels wind much more
effectually than the black hellebore (Hippocrates 1849).
Section XV: But unmixed hydromel, rather than the
diluted, produces frothy evacuations, such as are
unseasonably and intensely bilious, and too hot; but
such an evacuation occasions other great mischiefs, for
it neither extinguishes the heat in the hypochondria,
but rouses it, induces inquietude, and jactitation of
the limbs, and ulcerates the intestines and anus
(Hippocrates 1849)."
In describing treatment for "ardent fever

(causus)",

Hippocrates advocates administration of an emetic and
clyster;

"and if these things do not loosen the bowels,

with the boiled milk of asses

purge

(Hippocrates 1849)."

In the Appendix to the works On the Regimen of Acute
Diseases,

Section XXI,

he adds:

"Those who have the inferior intestines hot, and
who pass acrid and irregular stools of a colliquative
nature, if they can bear it, should procure revulsion by
vomiting with hellebore; but if not should get a thick
decoction of summer wheat in a cold state, lentil soup,
bread cooked with cinders, and fish, which should be
taken boiled if they have the fever, but roasted if not
feverish; and also dark coloured-wine if free of fever;

'
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but otherwise they should take the water from medlars,
myrtles, apples, services, dates or wild vine.
If there
be no fever...the patient should drink hot asses' milk
in small quantity at first, and gradually increase it,
and linseed, and wheaten flour, and having removed the
bitter part of Egyptian beans, and ground them, sprinkle
on the milk and drink; and let him eat eggs halfroasted, and fine flour, and millet, and perl-spelt
(chondrus) boiled in milk (Hippocrates 1849)."
In the Appendix to the works On the Regimen of Acute
Diseases,

Section XXXVIII,

for opening the bowels.

Hippocrates states:

"A medicine

Pour upon figs the juice of spurge,

in the proportion of seven to one:

then put into a new

vessel and lay past when properly mixed.

Give before food

(Hippocrates 1849)."
Hippocrates felt that purgatives were only beneficial
when the undigested material passed to the distal bowel.

In

the Appendix to the works On the Regimen of Acute Diseases,
Section VII,

he comments:

lately taken food,

"When fever seizes a person who has

and whose bowels are loaded with faeces

which have been long retained, whether it be attended with
pain of the side or not,

he ought to lie quiet until the food

descend to the lower region of the bowels,

and use oxymel for

drink; but when the load descends to the loins,
should be administered

a clyster

(Hippocrates 1849)."

Hippocrates attributed some states of diarrhea to an
excess of black bile in the body.

In the Appendix to the

works On the Regimen of Acute Diseases,
Hippocrates states:

Section VIII,
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"In those cases of fever in which the bowels are
loose, and the mind is disordered... such attacks appear
to me to be connected with black bile.
When in these
cases there is a colliquative diarrhea, I am of the
opinion that we ought to give the colder and thicker
ptisans, and that the drinks ought to be binding, of a
vinous nature, and rather astringent. (Hippocrates
1849) . "
Disorders of intestinal motility could even be traced to
dietary changes.
of Acute Diseases,

In the Appendix to the works On the Regimen
Section XVIII,

"Disorders connected with regimen,

Hippocrates writes:
for the most part,

make

their attack accordingly as any one has changed his habitual
mode of diet...but if the bowels are not opened,

he should

get his body rubbed with hot oil...Cheese produces flatulence
and constipation...The stalk and the juice of silphium
(assafoetida),

pass through some people's bowels very readily

(Hippocrates 1849),"

Roman Medicine
While the name of Hippocrates is associated with Greek
Medicine,

Galen is recognized as the father of Roman Medicine

(Figure 2).

Born at Pergamos in 133 A.D.,

concepts of observer,
1921).

Galen united the

experimenter and philosopher

(Osier

Unlike Hippocrates, we know a great deal about

Galen's life,

principally from his own writings.

taking up medicine at age 17,

After

he eventually gave public
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The frontispiece of the Latin translation of Galen
published by the Venetian printing house of Giunta
in 1541.
Reproduced from Sherwin Nuland's
Doctor's, the Biography. Vantage Books, New York,
1988.

lectures on anatomy in Rome in 162 A.D.

Galen soon found

himself the principle physician to Emporor Marcus Aurelius
after successfully treating the Emperor's stomachache after
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eating too much cheese.

Aurelius is said to have remarked:

"I have but one physician and he is a gentleman."

(Osier

1921) .
Perhaps the most prolific writer of the ancient
physicians,

Galen did not ally himself with any particular

school of medicine,
Hippocrates.

but regarded himself as a disciple of

Galen does not seem ever to have had the

opportunity to dissect the human body but he did carry out
large scale experiments which added to the basic corpus of
medical information
In his Hygiene

(Osier 1921).
(De Sanitate Tuenda),

Galen further

develops his ideas on digestion and disease.
chapter,

In his third

he describes the production and elimination of

excrements.

"Nature not only has provided organs for their

excretion but has endowed them with powers whereby some
attract the excrements,
them.

some propel them,

and some eliminate

And it is necessary that these should neither be

obstructed by anything nor impaired in their functions to
keep the body clean and free from impurities

(Galen 1951)."

Galen also proposed that various organs of the
intestinal tract had specific functions and roles in the
maintenance of health.
with many organs,

"She

(Nature)

provided the animals

some purging and separating the excrements,

some propelling them,

others collecting,

and others

eliminating them...For in the first place the excrement is
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separated and gradually propelled through all the intestines
into a large cavity called the rectum
In chapter XVIII,

(Galen 1951)."

Galen discusses the causes and

prevention of excrementary retardation:
"Now retardation of the excrements from the stomach
may arise from fault in the food and drink taken, or
from the stomach and intestines themselves.
From fault
of food or drink, retardation may occur on account of
their quality or quantity or the order and manner in
which they are taken.
On account of their quality, if
they are bitter, sour, or of a dry nature.
On account
of their quantity, if there is more or less than is
proper...
The causes of retardation of the excrements due to
the stomach and intestines may be intrinsic or acquired.
The intrinsic causes arise from faulty constitutions of
the body...There are eight different forms of acquired
disorders affecting the abdomen, each a dyscrasia of
individual sort.
Four of these are simple -- heat and
dryness, heat and moisture, cold and dryness, cold and
moisture.
Dyscrasias from internal causes arise when there is
in the food or drink something of a pharmacologic nature
which either warms or cools or dries or moistens, or
warm and dries, or produces any other combination of
these qualitites...From these causes the excrement of
the abdomen is suppressed (Galen 1951)."
Like Hippocrates,

Galen noted the importance of

evacuation of retained excrements.

In Chapter XIV:

universal docrine for all excrements,
to the cause of their retention."

"It is a

to employ the opposite

Similarly in chapter IX,

he discusses the preparation and use of cathartics and
enemas:

"But if after being constipated for two days,

do not move on the third day,
sufficient...(as is)
1951).

they

then a mercurial herb is

sea-cabbage,

calomel in barley

(Galen
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Galen further describes the importance of diet in the
maintenance of health in chapter V,

Diet and Venesection:

"And since also the hypochondrium in all such patients
becomes swollen and distended,

and whatever they take turns

easily to gas,

it would be better to give some long pepper

with the food;

for this dissolves the thickness of the

flatulent gas,

and also pushes towards the lower abdomen what

is sluggishly arrested in the hypochondrium,

and contributes

to the digestion of food...white pepper... so-called drug of
Diospolis... equal parts cummin and pepper and springwort and
nitre

(Galen 1951)."
Classical physicians attentively observed the character

of the urine and stools since this gave them insight into the
processes of digestion and concoction that were occurring in
their patients.

It was believed that alterations in these

processes contributed to disease.

Much of the therapy of

classical physicians was directed towards re-establishing the
normal balance of gastrointestinal function through the use
of medicated syrups.

DARK ACES
Following the death of Galen,

virtually no new

information was gained regarding anatomy or physiology until
the Renaissance.

The teachings of Galen survived,

through three lines of descent

(Osier 1921).

however,

A continuous

series of physicians practiced medicine in the Greek

I

-
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remained extant in the Eastern Empire but apparently were
unavailable to physicians of the West until the fall of
Constantinople in 1453

(Nuland 1988).

A second source of

Greek learning was the South of Italy where Greek remained
the spoken language until the thirteenth century.

The

schools of southern Italy and Sicily translated scientific
manuscripts directly from the Greek to Latin as early as the
eleventh century
Salerno

(d.

into Latin.

(Singer 1928).

1085),

for example,

Alphanus,

the Archbishop of

translated a work by Nemesius

These translations increased in numbers over the

following centuries.

No anatomical works by Hippocrates,

Aristotle or Galen are thought to have been available in
western Europe before the 12th Century

(Corner 1927).

The

major source of Galenic teachings during the late Dark Ages
in the West was from Arabian medicine.
The major stream through which Greek medicine reached
western Europe following the Eleventh Century was Arabian
medicine.

After the period of conquest,

down to the arts of peace.
centers of learning.

the Arabs settled

Baghdad and Cordova became great

Unfortunately,

the Greek teachings were

second or third hand by the time they were translated into
Latin.

Much of Galenic anatomy was translated into Arabic

not from the original texts but rather from synopses of Galen
such as Collecta medicinalia which was compiled by Oribasius
at the request of the Emperor Julian

(McMurrich 1930).
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largely from translations of The Seven Books of Paulus
Aegineta written in Alexandria in the seventh century

(Nuland

1988) .
Within a hundred years of the First Crusade,

many Arabic

texts were translated into Latin and became available in
western Europe

(Campbell 1926).

Constantine the African

between about 1070 and 1087 A.D. produced about 15 medical
manuscripts at Salernum
produced in 1127 A.D.

(Corner 1927).

Stephen of Antioch

a translation of Hali Abbas which

contained an important anatomical section

(Singer 1928).

Archbishop Raymond of Toledo established a school of
translation called "The House of Wisdom".

Gerard of Cremona

(1115-1185 A.D.)

translated at least 92 manuscripts from

Arabic to Latin.

The medical text which proved the most

influential in western Europe was the Canon of Medicine of
Avicenna which was largely based on Arabic translations of
Galen.

Thus,

in a brief time period beginning in the 12th

Century a prodigious volume of medical knowlege was
reintroduced into western Europe through Arabic sources.
These Latin translations contained much of Galenic anatomy
and physiology but the texts were derived from Arabic
translations of Byzantine synopses of Galen's works.

The

intervening centuries and nuances of different languages had
introduced many vagaries and errors into the Galenic
tradition.

■
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The flood of knowledge into western Europe from Arabian
sources also introduced Islamic customs.

Arabian medicine

divorced the practice of medicine from surgery.

The Arabic

authorities maintained that under certain conditions the body
was unclean.

This belief led to the Edict of Tours in 1163

which stated "Ecclesia abhuret a sanguine."
this edict,

As a result of

surgery was relegated to barbers and mountebanks

(Cambell 1926).

This distinction was warmly received by the

scholastic philosophy prevalent among the western scholars
since medicine lent itself better to logical argument as to
causes,

principles and treatment while surgical conditions

required prompt intervention

(McMurrich 1930).

This led to

the banishment of surgery from the universities during their
period of development.

Similarly,

anatomy was of little

value in the practice of the Arabian version of Greek
medicine.

The study of anatomy and function was

conventionalized into the reading of Latin translations of
Arabic summaries of Galen.

Cadaveric dissections were deemed

irrelevant since Galen was accepted as the authoratative
source of all anatomic information.

Unfortunately,

during

the descent of Galenic anatomy from the second century A.D.,
it was forgotten that Galen rarely studied human anatomy but
rather carried out dissections in various animals
particularly monkeys

(McMurrich 1930).

The differences

between Galenic teachings and actual human anatomy were only
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discovered in the Sixteenth Century when cadaveric
dissections became more prevalent.
Within a hundred years of the First Crusade,

many Arabic

texts were translated into Latin and became available in
western Europe.

The medical text which proved to be the most

influential in western Europe was the Canon of Medicine of
Avicenna which was largely based on Arabic translations of
Galen.

Avicenna

(930-1037 A.D.),

an Arabic philosopher,

delineated the processes of digestion in The Canon on
Medicine.

Avicenna

(Abu al-Hussain Ibn Abdullah Ibn Sina)

was born in 980 A.D.

in the village of Afshana in the

province of Bukkara,

Persia.

according to Persians,

"The Prince of Physicians"

his textbook,

The Canon on Medicine

became the textbook of medical schools in many European
medical schools.

Even today,

many consider the text an

excellent amalgamation of all the medical doctrines of
Hippocrates and Galen with the biological concepts of
Aristotle

(Lewis 1965).

Avicenna differed from Hippocrates on his definition of
disease and the significance of symptoms.
disease as

Avicenna defined

"an abnormal state of the human body,

which injurious effects result

(Gruner 1930)."

in virtue of
He no longer

judged a symptom a response to an illness but rather a result
of the disease.

He wrote:

"Symptom...a phenomenon consequent

upon this non-natural state of the body

(Gruner 1930)."

Indeed, he had veered so far away from the views of
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Hippocrates that Avicenna taught that a symptom could even be
the primary cause of the affliction:

"A symptom may be the

cause of a disorder

Thus,

(Gruner 1930)."

Arabian medicine

was not just a restatement of classical teachings but had
evolved away from some of the fundamental postulates of
Hippocrates and Galen.
Despite these differences in the definition of disease
and the importance of syptoms,

many of the views of Avicenna

were firmly founded on the teaching of the Greek tradition.
Avicenna,

like Hippocrates,

felt that disease could be

explained by an imbalance in the natural state of the body.
Health derived from an equilibrium between what the body
takes in and assimilates and what the body excretes.
Observation of the characteristics of stool could render
important information about the condition of the individual
and the balance of his natural faculties.

Avicenna wrote:

"The following are the characters (of stool) to
note:
the quantity; the consistence; the colour; the
form or shape; and the time occupied in the passage of
food through the bowel.
1.
Quantity.
If greater than the amount of food
taken, the reason lies in abundance of humours; if
smaller in amount, the reason lies in deficient amount
of humours, or in a retention of the food in the caecum
or colon...The reason may also be that the expulsive
power is insufficient.
2.
Consistence.
Moist excretion denoted defective
digestion or obstruction of some form; weakness of the
mesentery, so that it does not absorb sufficient water
from the food; fluxion from the head; some constituent
of the diet which causes the dejection to be moist.
If
the faecal matter is both moist and viscid, this shows
that there is colliquation in the tissues.
Fetor is
then present... Dry stool results from...a long delay in
the intestines.
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When fecal matter is both moist and hard, the
dryness is due to undue delay in the intestines due to
moisture which cannot escape.

When the feces are passed out too rapidly it is a
bad sign; it shows...that there is a weakness of the
retentive power.
A delay in the passage of fecal matter
through the body denotes a feeble digestion, coldness of
the intestines, abundant moisture (Gruner 1930)."

Avicenna described various regimens for the regulation
of intestinal motility.

Health could be maintained by

expulsion of the humors associated with disease.
practioner,

however,

The

needed to take into account such

variables as the age of the patient and the season of the
year.

"Articles of food which have a laxative action,

appropriate for elderly persons.--For summer:
prunes;

for winter:

dried figs cooked in water and in honey.

They must be taken before food,
(Gruner 1930)."

to have a laxative effect

The physician herded over his patient both

in health and in illness.
function,

Figs and

By proper attention to bowel

the physician could hope to prevent the development

of various maladies in his patients.
The physician could tailor his intervention to the
specifics of

the situation.

He could stimulate evacuation of

the rectum as outlined above or he could direct his attention
to the more proximal gut.
additional cathartics
tract.
stomach,
this

He described,

for example,

for the proximal gastrointestinal

"A medicine often leaves its odour behind in the
making it appear to be still there.

The remedy

is to partake of a barley ptisan or barley-meal

for

cake,
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for this will have the effect of cleansing the stomach
(Gruner 1930)."

The selection of various remedies required

meticulous evaluation of the clinical situation.
the character,

color and quantity of the stool,

selected his remedy for the patient.

Based on
the physician

Millenia of observation

ensured the precipitation of the expected result if the
physician carefully followed these guidelines which had been
first developed among the Greeks and passed down by the
Arabs.

15th Century
Physicians in western Europe gained access to the
original manuscripts of Hippocrates and Galen following the
crusades.

Careful study of these works revealed the

differences between Arabian medicine and the older Greek
traditions.

Many scholars of this period turned their

attention to the cleansing of Galenic medicine from Arabian
"heresies".

In the same spirit of the Protestant Reformation

which was sweeping western Europe at this time,
demanded the reinstitution of the "true"

physicians

teachings of Galen.

This is best illustrated by the writings of Michael Servetus
(1511-1553),

"theological reformer,

scholar,

geographer,

astrologist,

lawyer, mathematician,

scholar,

and spiritual

founder of the modern Unitarian movement", who was condemned
as a heretic by the Roman Church in Vienne and burned at the
stake by Calvin in Geneva

(Servetus 1989).

Servetus viewed
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the Arabs as the enemy of truth.

His treatise The Svruos,

which summarizes gastrointestinal function,

attempts to free

the "sacred authority of Galen" of Arabic inaccurancies
(Servetus 1989).

In his preface to The Svruos.

Servetus

writes:
"In our happy age, (Galen) once shamefully
misunderstood is reborn and re-establishes himself to
shine in his former lustre; so that like one returning
home he has delivered the citadel which has been held by
the forces of the Arabs, and he has cleansed those
things which had been bespattered by the sordid
corruptions of the barbarians (Servetus 1989)."
As a result of this effort to restore the true teachings of
Galen,

the attention of physicians was directed towards Greek

manuscripts of Galen rather than the investigation of
function of the parts of the body.
Michael Servetus extensively described the teachings of
Galen on the processes of digestion and concoction and the
genesis of disease in The Svruos.

Servetus also explained

the use of these syrups in the treatment of disease.
Servetus demonstrated the importance of "digestive
syrups" in the maintainence of health.

"A great many

disagree on the question of digestive syrups... They consider
them as doing nothing other than to digest or concoct,

and

content that bilious humors are not to be evacuated without
awaiting coction

(Servetus 1989)."

Like his predecessors,

Servetus postulated that

imbalances in intestinal motility led to disease.

<!
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"Therefore it is necessary that excrement, whether
it be hot or whether it be cold, either be driven out or
at least altered.
Not all excrement receives alteration
from nature, since not all food is concocted in the
stomach of every living thing, but there must be a
certain relationship of that which is concocted and that
which concocts.
Therefore what is entirely foreign can
in no way be made so that it may receive the service of
the nature, but as soon as possible it must be
endeavored to evacuate it; equally surely those things
which have been truly corrupted in the stomach had best
be driven out by vomiting or by purging (Servetus
1989) . "
Serevetus stressed the importance of the return of
normal bowel function:

"If expulsion is not achieved,

obstructions can occur in which not the concocting faculty
but the expulsion must be aided

(Servetus 1989)."

"Attempted purgation by disturbing the nature will
impede future concoction which will be aided by
quiet...In addition, not only must the crude humors then
be expelled, but others which are unprepared for
expulsion if they are blocking the passages of the crude
through which the others must be eliminated (Servetus
1989)."
Servetus employed a variety of "syrups"
of intestinal disorders.
from plants or animals,
bad humors,

in the treatment

These syrups were extracts derived
as well as oils.

By expelling the

restoration of health would occur.

"For a strong concocting force employing retention
surrenders nothing until it expels by thickening it to a
considerable consistency.
A weak one concocts,
retaining weakly, and discharges a thin liquid, as
though filtered out; or overburdened, it expels
prematurely.
Therefore from a weal concoction
attenuated excrements occur.
And so the reason for the prohibition of purgation
is that the crude humor, because of thickness and
coldness, is of slow movement and does not respond to
drugs; whence bad symptoms result and become worse in
the degree that the drug is more powerful in attraction
and the humor, because of the greater thickness,
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stronger in resistance or more fixed in the narrower
passages (Servetus 1989)."
Not only was it necessary for the removal of the crude
or bad humors from the body,
critical.

but the method was also

Slow humors needed to be removed quickly and by

the speediest route.

"The reason of our aphorism forbids

elimination of the crude humors from the stomach through the
bowel.

For the crude humor is slow in movement,

of the pylorus narrow,

the transit

and the twists of the intestine many

in which the humor may be delayed and especially in the
supporting mesenteric veins

(Servetus 1989)."

"For what Hippocrates and Galen fear is the
attractive strength of the drugs which, with no humor to
expel, usually arose bad symptoms.
"But if you assuage the belly with light drugs and
ease it from excrements, very often as we have already
said, that evacuation is not forbidden by Hippocrates
because it is not evacuation of crude humors; indeed,
evacuation of the bowel is permitted when venesection is
not permitted, since the belly having been freed and the
passages opened, the nature also more easily expels some
of the noxious humor.
But if by more powerful drugs you
attempt to expel the crude humors downward through the
bowel, you will adduce bad symptoms (Servetus 1989)."
Servetus stressed the importance of recognizing sickness
and instituting treatment immediately.

Recognizing that

patients responded better to treatment the sooner therapy was
administered,

Servetus commented:

"It is preferable to

eliminate by the bowel in the beginning,
clyster or a gentle drug,

by a suppository,

so that the intestines are relieved

of the burden of excrements and rendered better prepared for
the elimination of other juices

(Servetus 1989)."
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According to Servetus,

the uses of syrups are many and

varied.
"There are many and various uses of syrups... first,
as an aid to concoction...second, for aiding concoctions
in all parts Galen causes those things which extenuate
and comminute to precede... for they prepare the body,
open the passages, dissipate obstructions and remove the
thickness and stickiness of the humor, and as we shall
say, they eliminate something...Third, emision of blood
also occurs more easily with this aid where there is
abundance of crude humors (Servetus 1989)."
Later during his discourse,
syrups,

Servetus lists a variety of

each with their own purpose and indication:

"If in

the beginning of the sickness the bowel must be moved it is
safer to employ sweet potions of this sort... than by other
drugs harmful to it and which may destroy the nature already
weakened by the fever." pp 154.
"Of this class (of syrups) are those common potions
generally evacuating through the bowel, sweats and
urines, such as ptisan, mead and decoction of oxymel,
apomel and parsley.
"Those which at the same time cut up and control
the bowel are honey of roses, syrups of lavender,
hyssop, squill, cyclamen, or sowbread; decoctions of
cabbage, nettle and gallus decrepitus...Finally there
may be syrups which at the same time extenuate and
loosen the bowel such as dodder of thyme, polypody and a
fumatory of grass, or the same herbs with whey and a
fumatory of grass or of hops (Servetus 1989)."
Servetus also commented on the need for multiple
regimens to restore one's health.
medication too frequently,

If one uses a particular

tachyphalaxis could occur.

"A second matter for consideration which must not
be overlooked is that regarding the accustoming of the
nature to defecation...it ought to be accomplished with
not one but various medicaments... so that the bowel
ought to be loosened in turn by dog's-mercury, seacabbage, which is called soldanella, safflower, and
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turpentine.
For...if it becomes accustomed to only one,
it will (in time) disregard it (Servetus 1989)."

Sixteenth Century
In the Sixteenth Century,

Leonardo da Vinci's studies of

the alimentary tract provided new insights on current
knowledge of the intestines.

In 1508,

Leonardo met an

elderly patient at the Hospital of Santa Maria Nuova in
Florence,
autopsy,
death"

Italy.

Hours after his death,

da Vinci began an

"in order to ascertain the cause of so peaceful a

(Keele 1972).

After removing the omentum,

Leonardo displayed the

pattern of the small and large intestines in approximately
their correct relationships

(Figures 3,4).

This had been the

first time that the exact anatomical position had been
achieved.

In addition,

da Vinci discovered the appendix.

This so impressed the artist that he included a special
sketch of the region.

The force which propelled the

intestinal contents was supplied by wind,
Vinci.

according to da

He proposed that the appendix would provide a

reservoir for excessive wind in the intestines

(Kelle 1972).
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Figure 3:

Drawing from Leonardo da Vinci showing an
arrangement of the intestines.
DaVinci felt that
there was considerable variation in the arrangement
of the loops of small bowel.
From the stomach,
the intestine bends downward (duodenum), courses
upward (jejunum) and finally descends once again
(ileum) before becoming the large intestine.
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Figure 4:

A second arrangement of the intestines.
In this
varient, daVinci demonstrates that the terminal
ileum transverses the body before joining the
ascending colon.
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Although da Vinci's drawing of the alimentary tract were
unsurpassed,

his ideas of the physiology of digestion were

less impressive.

His one major error of observation was the

failure to note the peristaltic action of the intestines.
The reason for this is a simple one.

Da Vinci held deep

respect for life and deliberately excluded vivisection as a
method of physiologic study;
da Vinci was a vegetarian.

it has also been remarked that
Although he did recognize the

muscles which lined the intestines,

he felt that their sole

purpose was to prevent rupture of the tube:
"If you should say that the longitudinal muscles of
the stomach are for drawing down the food and the
transverse muscles for retaining it I shall reply that
that the whole intestine and everything adapted to
dilatation and contraction has transverse and
longitudinal fibers, as is seen in the texture of cloth.
And this is done in order that no force or power... shall
be able to break it (Kelle 1972)."
Da Vinci believed that propulsion of food down the
intestines was the result of action of the diaphragm and the
transverse abdominal muscles.

The opposing movements of

these two muscles were called "Motors of the food and air
within the human body"

(Kelle 1972).

"The flux and reflux of the two powers created by
the diaphragm and the abdominal wall are those which
compress the stomach and produce interrupted
expulsion...during which food is alternately expelled
and retained by the stomach (Kelle 1972)."
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Seventeenth Century
Andreas Vesalius

(1514-1564,

Figure 5)

and then the

comparative anatomists deduced the function of organs by
their gross appearance and eventually by experiments in live
animals.

Vesalius based his anatomic descriptions upon

cadaveric dissections

(Figures 6,7).

An alternative approach

evolved from the alchemists of the Renaissance.
Valentine,
stone

a Benedictine monk,

Basil

pursued both the philosopher's

(the substance which catalyzed the transmutation of

things such as lead into gold)
(Foster 1901)."

and also the nature of drugs

He pursued the role of vegetables and

minerals in the cure of disease.

He introduced many new

chemical compounds such as hydrochloric acid.

He also

developed a new unifying concept of nature which rested upon
three elements rather than the classical four.

These

elements represented the general qualities of all matter not
individual substances as we use this term:

sulphur

represented all things which were combustible;

mercury

embodied things which temporarily disappeared but could be
recovered;

and salt indicated things that were fixed such as

the ash which remains after combustion.

In addition,

he

postulated an "archaeus" which was the force or forces by
which God brought about events.
to Paracelsus

This philosophy was taught

(Theophrastus Bombast von Hohenheim 1493-1541)

by Bishop Trithemius.

The great contribution of Paracelsus
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was that he introduced into medicine and surgery a chemical
approach to disease

Figure 5:

(Pachter 1951)."

Woodcut portrait of Andreas Vesalius
Jan Stephan van Calcar.

(1514-1564)

by

FERZOCO,

Figure 6:

SJ

GUT MOTILITY IN CLASSICAL THERAPEUTICS -47-

The sixth figure of the fifth book from Andreas
Vesalius' De Humani Corporis Fabrics (1543)
demonstrating the relationship of the liver,
stomach and intestines in their true position.
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The seventh figure of the fifth book from De Humani
Corporis Fabrica.
Here, Vesalius provides a
detailed look at the small intestine and in
particular the terminal ileum and the ileocecal
junction.
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Paracelsus attacked the Galenic teachings of medicine.
He was a staunch empiricist who believed in his own power of
observation.

Paracelsus wrote that "Every physician must be

rich in knowledge,
books,

his patients should be his book,

mislead him...
1979)."

and not only of that which is written in
they will never

and by them he will never be deceived

(Jacobi

Paracelsus was an ardent advocate of experiment and

scorned a dogmatic approach to medicine.

"From his own head

a man cannot learn the theory of medicine,
which his eyes see and his fingers touch

but only from that

(Jacobi 1979)."

He

did not base his concept of disease upon anatomy but rather
on the effect of drugs on disease.

Thus,

he suggested that

diseases should be named by the drugs by which they are cured
(Foster 1901).

The impact of Paracelsus on the practice of

medicine is suggested by Robert Boyle

(1627-1691),

the father

of modern chemistry.
"Chymists have put some men in hope of greater
cures than formerly could be thought possible.
Before
men were awakened by the many promises and some cures of
Arnaldus de Villanova and Paracelsus... many physicians
used to pronouce a disease incurable.
They would rather
discredit the art and detract nature than confess the
two could do what ordinary physick could not (Pachter
1951) . "
The doctrines of Paracelsus persisted and contributed to the
growth of chemical physiology in the Seventeenth Century.
Ultimately,

these concepts of treating disease with chemicals

displaced the therapeutics of Hippocrates and Galen and
became the basis of modern therapeutics.
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Jean Baptiste Verduc wrote

on the importance of peristalsis and the circular valves of
the intestine to the separation of the chyle from the
excrements.

He wrote that:

"The intestines have a particular motion, in a
manner, like that of the Earth Worm, which is called
Peristaltick or Progressive... altogether necessary for
clearing the Chyle from the Excrements, and for
promoting its passage into the Milky Vessels.
The
Valves, which, at a certain distance from each other are
plac'd in the Intestines, contribute very much to the
retarding of the descent of the Chyle...all this brings
the Chyle nearer to the inside of the Pipe (Verduc
1704) . "

Eight e_en t h _ Century
In 1761,

Giovanni Battista Morgangni wrote De sedibus et

causis morborum -- The seats and causes of disease
8).

(Figure

The publication of this text marked the turning point

from an ancient conception of disease to the modern one.
Here we see the first combination of clinical history and
underlying pathology of most of the diseases that we
recognize today.
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A contemporary portrait of Giovanni Battista
Morgagni by the French engraver Jean Renard.
Reproduced from Sherwin Nuland's Doctor's, the
Biography. Vantage Books, New York, 1988.
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Morgagni recognized the importance of peristalsis in
maintaining health in the gastrointestinal system.

He

realized that digested food travelled down the intestine and
all waste passed through the colon before exiting the body
via the anus.

However,

in several diseased states, Morgagni

observed what he termed "antiperistalsis" or antegrade motion
of the intestines.
"Why, therefore, must we altogether, and at all
times, reject this cause, and suffer it to have no part
in the performance?
Is it because the peristaltic
motion is perhaps scarcely to be acknowledged any
longer?
How is it then?
Is it possible for the nature
of animals to be so chang'd, that in our age the
circumstance scarcely appears any more, which those very
ancient observers have seen, in consequence of whose
opinion Cicero has expresly written, "that the
intestines both constringe and relax themselves
alternately," either to agitate and prepare the food, or
to drive the remains of it, after concoction, downwards?
But left it should happen to any one of thise whom I
have refer'd to, in the preface to the second
Adversaria, near the latter end, that this passage of
Cicero, also, may seem, "to be quoted" by me, "by way of
severe reproach," I choose rather to neglect what may be
replied on this occassion, and to come down from the
ancients, to the more modern observers.
Shall I then
forget the great number of observations...of my own on
dogs, sheep and rabbits...a motion alternately
antiperistaltic.
(Morgagni 1769) Book III, Letter
XXXIV, Article 32."

As with others, Morgagni recognized the ability of
certain foods or clysters to alter intestinal motility and
function to help alleviate symptoms of disease.
"So he also prescribed various remedies to be taken
internally, and among thise the turpentine-resin, after
which was to be drunk a water, medicated with vulnerary

-T
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herbs...in the winter he recommended wine at the table,
and that of the domestic kind, in which, at the autumnal
season, when it fermented in the cask, such roots,
woods, and leaves...had been macerated (Morgagni 1769)
Book III, Letter XXXII, Article 9."

One of the major figures in surgery of the Eighteenth
century was John Hunter

(1728-1793).

Hunter introduced the

concept of experimental technique into surgery.

His tireless

work on comparative anatomy involving over five hundred
dissections led to many discoveries.
combine the disciplines of anatomy,

Hunter was the first to
pathology and surgery.

His discourses on physiology were considered "so far in
advance of his times that it was not comprehended
1895)."

In addition,

(Dennis

Hunter's pupils such as John Abernathy

would continue his philosophy of learning into the Nineteenth
century.
Despite the immense amount of anatomic discoveries
during this century,

treatment modalities for various

gastrointestinal disease continued to be based on centuries
old Galenic teaching.

William Cullen,

professor at the

University of Edinburgh, wrote on the Method of Cure in
Fevers,

"We form three general indications in the cure of

continued fevers.
re-action.

The first is to moderate the violence of

The second is,

to remove the causes,

the effects of debility. And,

or obviate

the third is to obviate or

correct the tendency of the fluids to putrefaction
1777) .

(Cullen

'
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Nineteenth Century
John Abernathy,
St.

a student of John Hunter and surgeon at

Bartholomew's Hospital in London provided new insight

into the changes that occurred in the contents of the
intestines.

Abernathy focused his attention to the function

of the intestines because he believed that he could treat
specific diseases by altering gastrointestinal function.
states:

"By correcting the obvious errors in the state of

the digestive organs,

the local disease, which had baffled

all attempts to cure by local means,
removed

He

has speedily been

(Abernathy 1809)."

Abernathy devoted an entire treatise to the remote
connection between the brain and the gut.

He wrote that "the

reciprocal sympathy which exists between the brain and the
digestive organs,

is generally admitted

(Abernathy 1809)."

In addition,

he commented "It is the remote sympathies,

according to

(Hunter's)

(Abernathy 1809)."

division,

of which I am now speaking

He reported that afflictions of the colon

and rectum might adversely affect the stomach.
"When digestion is imperfectly performed, the
functions of the intestinal canal will soon participate
in the disorders of the stomach... Should the disease
commence in the large bowel, it disturbs the functions
of the stomach, and secretion of the liver, and becomes
augmented in its turn by its sympathy with these parts
(Abernathy 1809)."
Thus,

Abernathy conceived that humoral actions mediated this

remote sympathy of the intestines on the stomach and liver.
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More than one hundred years would pass before further
experimental studies began to elucidate humoral factors
(hormones)

which might account for these observations.

Sir Astley Cooper,

an eminent surgeon in London in the

early nineteenth century,
was still Galenic.

demonstrated that clinical practice

"A deficiency of secretion from the

alimentary canal is the cause of a great number of the
diseases which human beings are subject

(Cooper 1839)."

With Rush's change of the classical definition of
disease in 1809,

(see earlier section of thesis)

there

followed a loss of the classical approach to the treatment of
disease.
The later half of the nineteenth century saw a dramatic
explosion in the field of medicine and,
surgery.
In 1857,

in particular,

Gut motility now became an area of active interest.
Pfluger noted that splanchnic nerve stimulation

inhibited intestinal movements.

Intestinal peristalsis was

further investigated by Ludwig.

In 1861,

he described the

swaying motions of the intestines between the intervals of
peristalsis.

He termed these movements Pendelbewegungen.

Auerbach and Meissner provided additional proof of an
intrinsic control mechanism of intestinal peristalsis with
the identification of intrinsic nerve plexuses in 1862.

Mall

demonstrated that the peristaltic wave occured in one
direction -- proximal to distal.

In his experiment of 1896,

Mall excised loops of small bowel and reversed it in situ.

-
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producing intestinal obstruction proximal to the reversed
section

(Garrison 1913).

Perhaps the most classic experiment of the 19th century
was performed by Bayliss and Starling in 1899 who confirmed
the hypothesis that intestinal peristalsis was a reflex
through the intrinsic ganglia.

The conclusion of 19th

century investigation of intestinal motility was that the
intestines were an autonomic mechanism which is regulated by,
but not dependent upon,

extrinsic nerves

(Garrison 1913).

Twentieth Century
Cannon observed peristalsis or "segmentation" of the
intestines by means of Roentgen rays in dogs and cats in
1902.

Ten years later in 1912,

Glenard made cinematographic

studies of the intestinal movements under normal and purged
states.

These studies were performed using rabbit bowel

which was isolated and constantly perfused with Locke's
solution

(Garrison 1913)

In 1902,

Hemmeter attempted to elucidate the effects of

various agents on the regulation of intestinal peristalsis.
Carbon dioxide,

hydrogen sulfide and methane were determined

to cause an increase in motility.
oxygen,

such as during a surgery,

bowel function.
various drugs,

Exposure of bowel to
resulted in a paralysis of

Hemmeter further evaluated the effects of
chemicals and toxins.

Belladonna and atropine

administration led to reduced irritability of Auerbach's

GUT MOTILITY IN CLASSICAL THERAPEUTICS
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Low doses

caused an increase in contractility while high doses
inhibited peristalsis.

Finally caffeine,

muscarin and

nicotine all resulted in increased motility

(Hemmeter 1902).

Hertz expanded on the regulation of motility in 1909.
After administration of a

bismuth meal,

transit time studies

revealed that the meal could be localized to the cecum after
an average of four hours. The effect of intestinal motility
caused by food entering the stomach was due to a reflex
action.

Hertz also tested the effects of certain meals on

transit time.
"Much of the activity of intestines depends on the
chemical stimulation produced by certain constituents of
the food and of the products of digestion.
Sugar...stimulates peristalsis in the small intestine
but not the colon.
Organic acids such as formic,
acetic, butyric, tartaric, citric and lactic acid
stimulate peristalsis in the small more than the large
intestine... Carbon dioxide and marsh gas produced by
fermentation of carbohydrates and sulpheretted hydrogen
produced by putrefacation of proteins actively stimulate
peristalsis in all parts of the intestine (Hertz 1909)."
Hertz also proposed treatment modalities for
constipation in much the same way as the ancient physicians -by means of altered diet.
"Treatment of constipation by diet is one of the
most effective methods of treatment...Mechanical
stimulation of intestinal movements depends on direct
irritant action of cellulose and distention produced by
the food.
The chief chemical stimulants of intestinal
activity are the sugars, organic acids and their salts,
which are present in vegetable food (Hertz 1909)."
Hertz divided his treatment modalities into four
pharmacotherapy groups.

In the first group he described the
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use of alkaloids.

Strychnine caused an increase reflex

excitability of the nervous system as well as increasing
muscular tone.

Atropine was classified in his second group.

Administration of this drug led to relief of "spastic
constipation."

The third group of drugs included opium,

morphine and codeine.

This group relieved constipation due

to pain leading to biliary and renal colic.

Finally the

fourth group of drugs included pilocarpine and physostigmine.
According to Hertz,

this group caused direct stimulation of

the motor and secretory nerve endings of the intestines
(Hertz 1909).
Gastrointestinal function is considered fundamentally
important for continued health.

Abnormalities in

gastrointestinal function led to disease.

Physicians would

then use the gastrointestinal tract to rid the patient of any
morbidic matters by purging them from the body.

Classical

concepts continued as the basis of medical therapeutics well
into the 20th century.

As a point of speculation,

many of

the prevalent diseases of the gastrointestinal system such as
diverticulitis,

irritable bowel syndrome and colon cancer may

be produced by alterations in motility.

Therapy might better

benefit from a more complete understanding of peristalsis and
the subsequent development of pharmacotherapeutic probes.
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MOTILITY
Review of Current Concepts

Galenic teachings dictated the concepts of disease and
intestinal function for hundreds of years.

In the eighteenth

century John Hunter's experiments led to new insight into the
mechanism of intestinal motility,

and since that time more

and more precise knowledge has accrued on regulation of
motility.

Disorders of intestinal motility continue to be a

major concern to mankind during the twentieth century.
irritable bowel syndrome,

The

diverticular disease and perhaps

even the genesis of colon cancer can be traced to alterations
of intestinal peristalsis.

Fgngtipn
In 1899,

the first major insight into the mechanism and

regulation of intestinal motility was proposed by Bayliss and
Starling:

"The peristaltic contractions are true coordinated

reflexes,

started by mechanical stimulation of the intestine,

and carried out by the local nervous mechanism...They travel
only in one direction,

from above downwards,

and are

abolished on paralysing the local nervous apparatus
1899) .

(Bayliss

--
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The main function of the small intestine is digestion
and absorption of nutrients.
role,

in part,

The intestines accomplish this

by the process of motility in which food

products mix with the digestive enzymes and the contact of
chyme with the absorptive cells over a sufficient length of
bowel,

and finally to propel remnants into the colon.

Motility can be broken down into two components,
peristalsis and segmentation.

Peristalsis consists of waves

of one or more contractions of circular muscle that is
propagated along the bowel.

This action has been described

as a moving ring of contraction.

The primary role of

peristalsis is propulsion of food boluses down the intestine.
Segmentation consists of two or more standing contractions,
separated by a short distance.

The purpose of these standing

contractions is to form an occluded segment thereby allowing
maximal mixing of luminal contents and absorption of digested
nutrients to the mucosal lumen

(Wingate 1983).

Smooth Muscle
The inner muscle layer of the small bowel is the
muscularis mucosae,

a thin layer of smooth muscle underlying

the mucosa itself.

The muscularis mucosae defines the

boundary between the mucosa and submucosa.

This layer is not

believed to play a significant role in the gross movements of
the small intestines but rather a role in mixing chyme
adjacent to the mucosal surface and possibly in modulating
the permeability of the mucosal layer.

REVIEW OF MOTILITY -61-
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Circular smooth muscle invests the entire small
intestine.

The circular muscle of the small bowel is thicker

than the longitudinal muscle layer and is the major source of
contractile activity.

Contraction of the circular muscle

layer will constrict the lumen.

Muscle cells in this layer

may play a role in coordinating propagation of slow waves
down the intestine with the longitudinal layer
1987,

(Weisbrodt

Bortoff 1983).
The outer coat of muscle is the longitudinal muscle

layer.

Contraction of this muscle mass will shorten the

intestine
layer,

(Wingate 1983).

Although thinner than the circular

it plays a major role in antegrade propagation of

intestinal slow waves.

The longitudinal arrangement of the

smooth muscles facilitates rapid electrical conduction,
compared to the perpendicular arrangement of the muscle cells
in the circular layer.
The cell membranes of small intestinal smooth muscle
exhibit a rhythmic depolarization
1971).

(Bortoff 1969,

This effect was first described by Alvarez and

Mahoney in 1922
slow wave,
activity

(Alvarez 1922)

and has been referred to as

basic electrical rhythm,

(Cohen 1979).

or electrical control

This rate of rhythmic depolarization

decreases distally down the small intestine
1964,

Christensen

Christensen 1966).

(Christensen

This is due to the inherent

pacemaker of the duodenum in initiating small intestinal
motility

(Herman-Taylor 1971).
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Smooth muscle cells undergo cyclical depolarizations.
Contraction only occurs when action potentials are
superimposed on the depolarization plateau.

The occurrence

of action potentials is signalled by the appearance of spike
bursts superimposed on the slow wave.

The timing of these

spike bursts is dictated by the slow wave and may be
considered to be "phase-locked" events
spike response is calcium dependent.

(Wingate 1983).

This

The primary role of

these slow-wave associated spike potentials is the mixing of
intestinal chyme by intestinal segmentation

(Cohen 1979).

Contractions of the wall of the small intestine are a
consequence of changes in lengths of the smooth muscle cells
that make up the tunica muscularis.

The temporal and spatial

patterns of intestinal contractions depend on factors that
influence these smooth muscle cells.

These factors include

the intrinsic properties of the smooth muscle cells
themselves,

the activities of nerves that constitute the

intrinsic nerve plexuses such as the myenteric plexus,

the

influence of the extrinsic sympathetic and parasympathetic
nerves that are distributed to the muscle and intrinsic
nerves,

and the influence of the various chemicals that reach

the nerves and muscles of the gut by endocrine and paracrine
pathways

(Cohen 1979).
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Intrinsic Nervous Control
The major control system of the small intestine appears
to reside within the intrinsic nervous system.
neurons,
wall.

nerve endings,

Numerous

and receptors lie in the intestinal

These nerve elements tend to be concentrated in nerve

plexuses,

the most prominent of which is the myenteric plexus

of Auerbach between the longitudinal and the circular muscle
layers.

The neurons in the plexus receive input from several

sources,

including receptors in the mucosa and in the muscle

wall,

from other neurons in the plexus,

nerves.

and from extrinsic

They form an important neural control center acting

in effect as a "little brain" of the gut

(Vantrappen 1975).

The regulatory capacity for the myenteric plexus has
been difficult to evaluate.

Research has focused on the

inhibition and activation of these nerves in various
intestinal preparations.

Various neuronal agonists and

antagonists have been utilized in hoping to elucidate the
regulatory mechanisms of neural control.

When an isolated

segment of small intestine from a cat is placed in an organ
bath,

intermittent contraction is evident.

tetrodotoxin,
bath,

a potent neuronal antagonist,

When
is added to the

the segment contracts at the rate of the frequency of

the slow wave

(Biber 1973,

Bortoff 1975).

Recordings from

neurons within the myenteric plexus showed that many of these
neurons were active during those periods when the bowel was
not contracting and that tetrodotoxin blocked activity of
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those neurons

(Ohkawa 1972).

Thus,

it appears that there are

tonic inhibitory nerves in the plexus that actively suppress
contractions of the circular smooth muscle.

Additional

studies supporting this hypothesis come from investigations
of aganglionic segments of bowel.

Wood demonstrated that

these aganglionic segments lack a normal myenteric plexuses
and are tonically contracted

(Wood 1972).

Electrical or

chemical stimulation of the nerves within the myenteric
plexus also affects contractions of the muscle

(Hidaka 1969,

Wood 1975, Wood 1979, Weisbrodt 1987).
Bennett postulated that from a neuropharmacologic
viewpoint four types of efferent nerves are involved in the
control of intestinal motility:
adrenergic inhibitory;
inhibitory;

cholinergic excitatory;

nonadrenergic,

and probably,

noncholinergic

noncholinergic excitatory nerves

(Bennett 1975) .
Peristalsis consists of two simultaneous events:
ascending contraction,
secondly,

proximal to a food bolus,

and

descending inhibition with smooth muscle relaxation

distal to the bolus.

These pressure zones allow food to be

pushed down the lumen

(Makhlouf 1989,

Ascending contraction:

1990).

The present model for the

regulation of peristalsis has been proposed by Makhlouf
(Figure 9).

Interneurons projecting cephalad in the

myenteric plexus coordinate a wave of contraction proximal to
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This is referred to as ascending contraction.

Stretch receptors in the intestinal wall synapse with

Figure 9:

Mechanism of intestinal peristalsis.
Prokinetic
agents (here shown being released from a neuron)
cause smooth muscle contraction.
This in turn
leads to generation of a high pressure zone
proximal to a food bolus.
Stretch receptors,
sensing the bolus within the lumen, cause release
of inhibitory agents such as vasoactive intestinal
peptide distally.
This release leads to smooth
muscle relaxation and generation of a low pressure
zone distal to the food bolus.

interneurons in the myenteric plexus.

These project

proximally and synapse with prokinetic cholinergic neurons,
orad to the bolus.

The cholinergic neurons cause contraction

.
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in the circular muscle layer which propels the bolus
distally.
Descending Inhibition:
ascending contraction,

Synchronous with

descending inhibition is initiated by

sensory receptors in the intestinal wall.
stretch from a food bolus in the lumen,
ganglia in the myenteric plexus.

to the network of

The impulse is transmitted

down a relay of three inhibitory neurons,
are somatostatin,

These convey

whose transmitters

opioid and vasoactive intestinal peptide,

in sequence.
Stimulation of somatostatin neurons causes inhibition of
opioid neurons.

The opioid neurons exert a continuous

inhibitory restraint on VIP neurons.

Release of somatostatin

therefore inhibits release of the opioid mediator and the VIP
neurons are no longer inhibited.

The final inhibitory VIP

neurons project into the circular muscle layer.

Release of

VIP into the muscle coat causes smooth muscle relaxation,
descending inhibition results.
the bolus then relaxes,
down the intestine

Intestinal muscle distal to

enabling it to be propelled further

(Makhlouf 1990).

This system produces

synchronous contraction orad to the bolus,
distal to the bolus,

and

and relaxation

enabling it to be propelled down the

lumen.
Research has focused on the "transition zone" between
the high and low pressure zones which are well characterized.
Researchers suggest there must be some counter-regulatory

*
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mechanism between the high pressure zone created by
prokinetic agents and the low-pressure zone due to vasoactive
intestinal peptide release

(Figure 10).

Figure 10: Research has focused on counter-regulatory agents
involved in intestinal peristalsis.
Between the
high and low pressure zones generated by prokinetic
and inhibitory agents, there must exist some
mechanism which reverses the low pressure zone and
allow generation of a high pressure zone by
prokinetic agents.
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Extrinsic Nervous Control
The small intestine receives an extrinsic innervation
from both divisions of the autonomic nervous system,
parasympathetic and sympathetic.

The extrinsic innervation

to the small bowel is provided by the vagal and splanchnic
nerves

(Gonella 1978,

Gershon 1981).

The exact role played

by these extrinsic nerves remains incompletely understood.
Small intestinal motor activity is essentially unaffected by
either vagotomy or splanchnicectomy

(Vantrappen 1985) .

Parasympathetic input to the small bowel arises from the
vagus which innervates the bowel to the mid-transverse colon.
Pre- and post-synaptic neurons synapse in the vagal nucleus
in the midbrain,

and the left and right vagi pass down the

esophagus as anterior and posterior vagi respectively.
Vagal input to the small bowel comes predominantly from
the posterior vagus, which passes through the celiac and
superior mesenteric plexi, without synapsing.
fibers,

like the sympathetic counterparts,

bowel via the arterial tree

(Longo 1989).

The vagal

reach the small
The vagus is

connected to the muscle through the myenteric plexus which
then interfaces with intestinal smooth muscle cells

(Wingate

1983) .
Sympathetic

(thoracolumbar)

input arises from the

intermedio-lateral cell column in the spinal cord and presynaptic fibers pass through the sympathetic chain without

.. I

*
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synapsing.

The fibers pass to the celiac and superior

mesenteric ganglia, where they synapse with postganglionic
fibers.

The post-synaptic fibers travel together with vagal

fibers via the arterial tree to the small bowel.
fibers convey not only efferent signals,

Sympathetic

but also noxious

stimuli from the gut to the central nervous system.
Early studies on the effects of nerve stimulation and
transection on intestinal contractions demonstrated,
general,

in

that activation of the parasympathetic nerves

increased contractions and activation of the sympathetic
nerves decreased contractions
Kosterlitz 1968).

(Kewenter 1965,

Kewenter 1970,

Researchers have also demonstrated that

certain reflexes depended on integrity of extrinsic
innervation

(Gernandt 1946,

Gregory 1947,

Johansson 1967).

The primary reflex studied was the intestinal inhibitory
reflex, which is characterized by inhibition of intestinal
contractions at all adjacent loci during marked distension of
an area of bowel.

This reflex appeared to depend on

integrity of the sympathetic nerves.

Some studies implicated

participation of the brain and spinal cord,

since sectioning

of the splanchnic nerves abolished the reflex.
studies, however,

suggested that the reflex involved only the

prevertebral ganglia,

since the reflex persisted after

splanchnic section but not after ganglionectomy
1987) .

Other

(Weisbrodt
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Several studies have been designed to determine the
neural pathways between the intestine and the prevertebral
ganglia

(Kreulen 1979A,

Szurszewski 1976).

Both afferent and

efferent fibers have been demonstrated
electrophysiologically.

Also,

an intestinointestineal reflex

has been observed in a preparation in vitro that contained
only the colon,
nerves

the prevertebral ganglia,

(Kreulen 1979B).

and interconnecting

Thus reflex arcs contained solely

within the intrinsic and prevertebral ganglia do exist and
they are functional.

These studies were performed on

preparations of colon.

Whether or not they exist for the

small intestine remains to be determined

(Weisbrodt 1987).

Kosterlitz delineated the spinal and supraspinal
influences on the intestine

(Kosterlitz 1968).

Although

there have been studies which indicate that certain reflexes
and patterns of motility can be expressed in preparations
lacking central nervous connections,

one should not conclude

that the central nervous system is not needed or does not
influence patterns of motility.

There are areas within the

brain that when stimulated cause either an increase or a
decrease in intestinal contractions

(Roman 1987).

Thus

higher centers can alter activity of other neural and
muscular tissue.

Also,

endogenous peptides,

autocoids and

pharmacologic agents injected into the cerebral ventricles
alter contractions and intestinal transit

(Bueno 1985).

activation of structures within the brain is thought to

Such
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elicit a response by way of the autonomic nervous system.
However,

there are data to indicate that in some instances a

humoral substance may be involved

(Bardon 1984) .

The site of action of the extrinsic nerves could be
either on the smooth muscle cells themselves or on the nerves
of the myenteric plexus

(Gabella 1972,

Youmans 1972).

Structural and physiologic studies indicate that extrinsic
nerves end at the level of the myenteric plexus.

This is

true for both sympathetic and parasympathetic nerves.

A few

adrenergic nerve terminals can be found within the muscle
layers themselves,
Therefore,

but their function is not clear.

extrinsic nerves probably function to regulate and

modulate activity of the intrinsic nerves, which in turn
affect the intrinsic activity of the intestinal smooth
muscle.
Cholinergic neurons
Acetylcholine is the transmitter of many,

if not all,

of

the preganglionic vagal and sacral fibers that reach the
intestines.

Researchers have demonstrated that cholinergic

preganglionics innervate both excitatory and inhibitory
neurons

(Kosterlitz 1964).

Kosterlitz also demonstrated that

intrinsic excitatory ganglion neurons are also cholinergic
(Kosterlitz 1968).

Segments of guinea pig ileum maintained

in vitro spontaneously release large amounts of acetylcholine
(Chujyo 1953).

This spontaneous release reflects the

spontaneous activity of the enteric nervous system.

.
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Researchers reported that there is a larger release of
acetylcholine when the gut is stimulated electrically
(Gershon 1981).

This extra store of acetylcholine probably

arising from neurons within the enteric nervous system

(Paton

1968) .

HORMONAL

CONTROL

CHOLECYSTOKININ
In 1928,

Ivy and Oldberg described the release of a

mediator from small bowel mucosa by infusing fat into the
duodenum.

The mediator caused contraction of the gallbladder

when reinfused into the animal and was thus named
cholecystokinin

(CCK)

was

isolated from hog intestine as a 33-amino-acid peptide.

It

possessed,

(Thompson 1984).

Cholecystokinin

in addition to gallbladder-contracting activity,

pancreatic-enzyme-stimulating activity
In the intestine,
cells,

(Mutt 1968).

CCK is found in open-type endocrine

most abundant in the duodenum and proximal jejunum.

It has also been isolated in neurones in the myenteric and
submucosal plexi of both the small and large intestine
(Gutierrez 1974,

Stewart 1977,

Amer 1972).

The chemical structure of CCK is complicated by the
natural occurence of multiple molecular forms.
to the 33-amino acid form (CCK-33),

In addition

intestinal extracts

contain roughly equivalent amounts of a larger form composed
of 39 amino acids

(CCK-39)

and an even larger form containing
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58 amino acids

(CCK-58)

(Eysselein 1982,

Mutt 1968).

The

principle smaller form is the carboxy-terminal octapeptide
(CCK-8)

that has been isolated from sheep and human brain

(Dockray 1977,

Reeve 1984, Walsh 1987).

CCK and gastrin have several common features.
carboxyl-terminal pentapeptide amide sequence,
the two peptides,
both.

The

identical in

includes the biologically active region for

The six amino acid extensions that immediately follow

the pentapeptide sequence are the same in the human CCK and
gastrin precursors

(Gly-Arg-Arg-Ser-Ala-Glu).

Carboxyl-

terminal amidation of CCK and gastrin involves the action of
an enzyme that converts glycine-extended phenylalanine to
carboxyl-amidated phenylalanine

(Bradbury 1982,

Eipper 1985).

The principal structural difference related to biological
activity between gastrin and CCK is the invariant presence of
a tyrosine O-sulfate group in the seventh position from the Cterminus in CCK,

while the tyrosine residue located in the

sixth position from the C-terminus in gastrin may be either
sulfated or non-sulfated

(Walsh 1987).

Bertaccini and Levant have both reported that CCK
analogs markedly decrease transit time of contrast material
through the human intestine

(Bertaccini 1971,

Levant 1974) .

CCK causes disruption of the fasting pattern of myolectric
activity in canine intestine,

but the stimulated spike

potentials are not identical to those that occur after a meal
(Mukhopadhyay 1977).

CCK-8 produced contraction of circular
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muscle and relaxation of longitudinal muscle of dog small
intestine that were antagonized by atropine,

tetrodotoxin,

and depolarizing concentrations of nicotine,

suggesting that

CCK-8 interacts with a nonnicotinic receptor on
postganglionic cholinergic neural elements in intestine
(Stewart 1977,

Walsh 1987).

MOTILIN
Motilin,

purified from hog upper intestine, was

characterized by its ability to stimulate gastric motor
activity in antral and fundic pouches in dogs and by
stimulation of gastric pepsin but not acid secretion

(Brown

1971).
Motilin is located in the endocrine-paracrine cells of
the duodenal and jejunal mucosae
Smith 1981).

(Polak 1976,

Pearse 1976,

It is a linear peptide containing 22 amino

acids and has a molecular weight of 2,700.

Canine and

porcine motilin differ in amino acid residues at positions 7,
8,

12,

and 14,

accounting for differences in immunoreactivity

found with some antibodies

(Poitras 1983,

Reeve 1985).

Researchers have reported that synthetic motilin,

13-N-Leu,

and natural porcine motilin caused contractions of isolated
segments of rabbit intestine
addition,

(Shimizu 1976, Wunsch 1976).

these contractions were not associated with

excitation of cholinergic receptors nor with the release of
acetylcholine from nerves.

In

FERZOCO,

REVIEW OF MOTILITY -75-

SJ

Motilin is a hormone of the fasting state unlike most
gut hormones which are released postprandially.

Several

physiological phenomena can induce rises in plasma motilin.
Mitznegg demonstrated that duodenal acidification increased
motilin levels 90% over baseline.

He additionally discovered

that fat ingestion increased motilin levels 65% whereas
protein and glucose ingestion failed to change observed
levels

(Mitznegg 1976).

Motilin has significant effects on gatrointestinal
smooth muscle.

Intravenous infusion of motilin in conscious

dogs during the interdigestive period initiates myoelectric
complexes in the antroduodenal region that are propagated
distally in the small intestine and appear identical to the
myoelectric complexes that appear spontaneously at 80- to 90minute intervals during fasting

(Wingate 1975).

However,

it

has little effects on the postprandial pattern of intestinal
activity

(Itoh 1976).

Motilin caused contraction of gastric and intestinal
muscle strips from humans and rabbits in vitro,

and this

stimulation appeared to be direct rather than by neural
mediation

(Strunz 1975).

The stimulation was abolished by

the calcium antagonist verapamil.
reported with synthetic motilin

Similar results have been

(Strunz 1975, Walsh 1987).

GASTRIN
Gastrin was the first gastrointestinal peptide for which
the structure was determined.

Subsequently,

several

.
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molecular forms have been identified.

Noyes and Yoo

identified the gene that encodes gastrin by the use of mRNA
isolated from porcine antrum

(Noyes 1979,

Yoo 1982).

Wiborg

isolated the human gene from a human genomic DNA library
(Wiborg 1984).
Earners localized various forms of gastrin in the
gastrointestinal tract.

He discovered that the most abundant

form of gastrin found in the antrum is the heptadecapeptide C17.

The 34-amino acid peptide,

G-34, was found to be more

abundant than G-17 in the human duodenum

(Lamers 1982).

The effects of gastrin on smooth muscle in vitro include
stimulation of muscle contractions and electrical activity.
Morgan reported that pentagastrin is about as potent as G-17
and G-34 on canine antral muscle
systems,

(Morgan 1978).

In many

gastrin appears to act directly on smooth muscle

cells to elicit contraction.

In dog antrum,

pentagastrin

stimulates longitudinal muscle partially by release of
acetylcholine from nerves, whereas it stimulates circular
muscle directly

(Szurzewski 1975).

In some preparations,

there is evidence that it exerts its effect entirely by
release of acetylcholine or substance P from nervous
elements.

This is especially evident in guinea pig ileum

where contractile responses to both gastrin and CCK peptides
are abolished by tetrodotoxin and reduced by atropine and by
substance P desensitization
Walsh 1987) .

(Hutchinson 1981, Vizi 1974,
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ERYTHRQMYCIN
Erythromycin,

a macrolide antibiotic,

stimulates

motility throughout the gastrointestinal tract.

It promotes

gastric emptying after post-vagotomy gastroparesis
1990)

(Mozwecz

and stimulates antral and duodenal peristalsis

(DiLorenzo 1990).

In the small bowel,

anterograde and retrograde propulsion
1989),

it stimulates both
(Otterson 1990,

Inatomi

accounting for the diarrhea and abdominal cramps often

seen as a consequence of erythromycin ingestion.
large bowel,

In the

the drug may have a therapeutic role in colonic

pseudoobstruction.

Intravenous infusions of erythromycin at

doses far below those needed for its antimicrobial activity
induce a pattern of propagative gastrointestinal motility in
the fasting state strongly resembling the interdigestive
migrating motor complex

(Itoh 1984 and 1985).

The prokinetic actions of erythromycin in the small
bowel mimic the actions of endogenous motilin administration,
since motility is stimulated only in the interdigestive phase
(Inatomi 1989,

Itoh 1984,

1981, Wingate 1976,
In addition,

Strunz 1975,

Lang 1986,

Itoh 1976,

Adachi

Depoortere 1990).

Peeters demonstrated that erythromycin binds in

vitro to motilin receptors,
surface

Itoh 1985,

(Peeters 1989).

located on the smooth muscle cell

These receptors are distinct from

the traditional cholinergic receptors,

although activation of

each results in smooth muscle contraction.

REVIEW OF MOTILITY
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Arms trong demonstrated that erythromycin-stimulated
ileal motor activity was not inhibited by neuronal blockade
with tetrodotoxin, muscarinic blockade with atropine,
opiate antagonism with naloxone

(Armstrong 1992).

or

These

results indicated that erythromycin acted by the direct
stimulation of smooth muscle motor activity.

Further studies

indicated that the prokinetic effect of erythromycin was
calcium channel-dependent since the nonspecific calcium
channel blocker verapamil reversibly inhibited this effect.
Finally,

Armstrong demonstrated that the specific calcium

channel blockade with dihydropyridine also reversibly
inhibited erythromycin-stimulated ileal motor activity.
These results suggested that erythromycin stimulated ileal
motor activity by a direct effect on smooth muscle cells
which was dependent upon both dihydropyridine-sensitive
calcium channels

(Armstrong 1992).

Armstrong additionally showed that erythromycin
stimulated a concentration-dependent increase in small bowel
motility which was not inhibited by atropine and the opiate
antagonist naloxone.

Furthermore,

pre-treatment with

tetrodotoxin had no effect on the erythromycin-induced
activity.

The prokinetic actions of erythromycin were

therefore not mediated via the classical cholinergic
receptor,
receptors.

nor via inhibition of the inhibitory opiate
The lack of any inhibition with tetrodotoxin

indicated that the receptor for erythromycin was located on

'
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the smooth muscle cell surface,
pathway

(Armstrong 1992).

rather than within a neural

These findings were consistent

with previous studies that indicated that target receptor of
erythromycin was in fact the smooth muscle motilin receptor
(Peeters 1989) .
Contraction of smooth muscle involves calcium entry into
the cell and Ca2+-calmodulin complex formation.

This in turn

activates myosin light chain kinase and subsequent cross¬
bridge formation

(Yoshino 1989).

Entry of calcium into the

cell is regulated by receptor-linked calcium channels.
Currently,
"t,"

three subtypes of calcium channels are described,

"1," and "n," although the classification is still

evolving

(Nowycky 1985,

Tsien 1987,

Bean 1989).

VASOACTIVE INTESTINAL PEPTIDE
In 1970,
mucosa.

Said and Mutt isolated VIP from porcine gut

When this was re-injected intravenously,

and venous dilatation resulted.

arteriolar

They therefore named the

mediator vasoactive intestinal peptide

(Buchanan 1979,

Thompson 1984) .
Vasoactive intestinal peptide is not present in
mammalian endocrine cells of the gut.
neurones of the enteric nervous system,

It is found in
as well as the

central nervous system, urological tract,
system and lungs.

cardiovascular

In the gut, VIP is found in all the
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component layers but is most abundant in the neuronal plexi
(Korman 1989) .
Vasoactive intestinal peptide release is seen after
ingestion of a meal, but the specific stimulus is not known.
Vagal stimulation releases VIP,
acetylcholine administration

and this can be reproduced by

(Chijiiwa 1986).

blocker hexamethonium inhibits this,

The ganglion

suggesting that

preganglionic cholinergic nerves mediate VIP release.
In the gut,
characterized.

the actions of VIP have been fairly well
It is a potent secretagogue,

stimulating

chloride secretion and inhibiting sodium absorption.

It

appears to act via adenylate cyclase mediated increase in
intracellular cAMP

(Grider 1988).

Its action on gut motility

involve relaxation of circular smooth muscle,
increasing intracellular levels of cAMP.

again by

VIP plays an

important role in descending inhibition of intestinal
peristalsis.

Descending inhibition distal to a food bolus

allows anterograde propulsion down the intestine
1989,

(Makhlouf

1990).

DISORDERS

OF

INTESTINAL

MOTILITY

IRRITABLE BOWEL SYNDROME
The irritable bowel syndrome

(IBS)

is one the leading

diseases of gastrointestinal function in the Western world.
The irritable bowel syndrome refers to a well-characterized
complex arising from interactions among the digestive tract,

'
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the psyche,

and luminal factors

(Camilleri 1992).

Studies

have demonstrated that 15%-20% of the population suffer from
IBS and that most do not seek medical attention for their
symptoms

(Drossman 1992).

An international working panel has provided a definition
for this troubling disorder:

"The irritable bowel syndrome

is a functional gastrointestinal disorder attributed to the
intestines and associated with symptoms of pain and disturbed
defecation and/or symptoms of bloatedness and distension
(Drossman 1990).
First recognized in 1849,

Cumming commented on how

constipation and diarrhea could occur in the same patient
(Cumming 1849).

Indeed,

for nearly 150 years,

the complete

etiology and treatment of patients with the irritable bowel
syndrome still eludes physicians.
What is known about patients suffering from IBS is that
pain symptoms are produced by motor hyperreactivity.

Alvarez

noted abnormal peristalsis in a patient with the irritable
bowel syndrome

(Alvarez 1943).

Horowitz and Farrar were the

first to observe clustered contractions during periods of
abdominal colic

(Horowitz 1962).

Cann demonstrated that

patients with IBS and diarrhea had accelerated whole-gut
transit times and,
was noted

in some patients,

(Cann 1983).

fast orocecal transit

Vassallo showed accelerated transit

in the ascending and transverse colon in patients with
diarrhea-predominating IBS

(Vassallo 1992).

*
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Treatment modalities for IBS have been as varied as the
symptoms themselves.
pharmacotherapy,

hypnosis,

with limited success.
anticholinergics,

Physicians have tried a variety of
and behavior modification -- all

Several drugs such as

opioids,

calcium channel blockers,

cholecystokinin antagonists,

and selective serotonin

antagonists have failed to provide symptomatic relief of
patient symptoms.
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NEUROENDOCRINE REGULATION OF GUT
MOTILITY
Neuropeptide Y and Peptide YY

John Abernathy was the first to describe the neuro-gut
axis

(Abernathy 1809).

Bayliss and Starling founded the

discipline of endocrinology with the publication of "The
Mechanisms of Pancreatic Secretion" in 1902.

They described

the substance "secretin" and defined the term "hormone."
Since that time,
identified.

a plethora of gut peptides have been

In particular, vasoactive intestinal peptide,

peptide YY and neuropeptide Y appear to play a prominent role
in gastrointestinal motility.

ISOLATION AND CHARACTERIZATION
Peptide YY

(PYY)

and neuropeptide Y

(NPY)

are members of

a family of peptides which are structurally related to
pancreatic polypeptide.

Tatemoto first isolated PYY from

porcine small intestine in 1980

(Tatemoto 1980).

A

characteristic of many biologically active peptides is the Cterminal amide structure.

By employing a technique which

isolated peptides with C-terminal amides,

Tatemoto isolated a

36-amino acid peptide and discovered that it contained an N-
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terminal tyrosine as well as a C-terminal amide.
was called peptide YY
residues

(PYY)

(tyrosine = Y).

The peptide

due to these terminal tyrosine

It was this same technique that

enabled Tatemoto in 1982 to isolate neuropeptide Y
porcine brain

(NPY)

from

(Tatemoto 1982).

The sequences of PYY and NPY were determined to be quite
similar not only to each other but also to pancreatic
polypeptide
sequenced.
peptides.

(PP) which Chance had isolated
Thus,

(Chance 1974)

and

PYY, NPY and PP constituted a new family of

Their sequences are depicted in Figure 11.

PYY

and NPY share nearly 70% homology while PYY and PP share 50%
homology.

PYY:

YPAKPEAPGEDASPEELSRYYASLRHYLNLVTRQRY

NPY:

YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY

PP:

APLEPVYPGDDATPEQMAQYAAELRRYINMLTRPRY

Figure 11: The amino acid sequence of PYY, NPY and PP.
Peptide YY shares nearly 70% homology with NPY and
50% homology with PP.
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DISTRIBUTION OF PYY
Although PYY and NPY share structural homology,

the two

peptides exhibit distinct anatomical distributions.
Immunohistochemistry provided the first clues to the
localization of PYY containing cells.
five species,

Utilizing tissue from

Lundberg demonstrated that PYY-like

immunoreactivity occured almost exclusively in endocrine
cells of the gastrointestinal mucosa.

PYY immunoreactivity

was also noted to be 100-fold higher in the colon than the
duodenum in the rat

(Lundburg 1982A).

Further work revealed

that PYY immunoreactivity occured in a variety of species
including toad and grass lizard
fowl
rat

(El-Salhy 1982B);

guinea pig and cat

(Bottcher 1984); dog

Salhy 1983A);

and man

(El-Salhy 1982A);

(Taylor 1985);

(El-Salhy 1983B).

domestic

(El-Salhy 1982A);

rhesus monkey

(El-

PYY-containing cells

were shown to be present in the gastrointestinal tract from
the stomach down to the rectum.

Bottcher described PYY

immunoreactivity in the intestine and more specifically in
the basal portion of the crypts of Lieberkuhn

(Bottcher

1984) .
Researchers next focused on the morphology of the PYYproducing cell.
labelling,

Bottcher, utilizing protein A-gold

described PYY-containing secretory granules in a

population of L-type endocrine cells in feline colon and
human rectum

(Bottcher 1986) .

El-Salhy described these cells
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extending from the basal lamina to

(El-Salhy 1983A).

ultrastructural level,

He noted that at the

PYY-immunoreactivity was localized in

a basal granulated cell containing round or slightly oval
electron-dense granules with an average diameter of 190 nm
(range 110-390).

Studies have shown that PYY-immunoreactive

cells emit cytoplasmic processes to the neighboring goblet
cells

(El-Salhy 1983B).

This fact suggests the possibility

of a paracrine function for these cells

(Kishimoto 1985).

PYY has been shown to co-localize with enteroglucagon
within the L-cells of the colon
Rachedi 1984).

(Bottcher 1984 and 1986,

Ali-

Ali-Rachedi demonstrated co-localization of

PYY and enteroglucagon immunoreactivity in both rat and human
tissue

(Ali-Rachedi 1984).

El-Sahly reported that PYY and

enteroglucagon were co-stored in only some cells in the
monkey

(El-Salhy 1983A)

Salhy 1983B).

and did not co-localize in human

(El-

Bottcher demonstarted coexistence of PYY and

enteroglucagon in sequential staining of tissue from rat,
and man

(Bottcher 1984).

pig

Since the two peptides were

released from the same cell,

it was hypothesized that perhaps

PYY was contained in the proglucagon molecule.

This proved

not to be true and it was suggested that these endocrine
cells are capable of expressing two separate gene products
(Bottcher 1984 and 1986).
Nilsson demonstrated that L-cells were the sole source
of PYY and enteroglucagon in the rabbit colon and that L-

'
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cells contain different populations of secretory granules.
He proposed that the existence of different secretory
granules in L-cells may explain the selective release of PYY
and enteroglucagon observed in the rabbit colon

(Nilsson

1991) .
Ali-Rachedi reported that radioimmunoassay of human
fetal pancreatic extracts revealed the presence of PYY
immunoreactivity.

PYY concentrations declined with age in

contrast to the amount of glucagon which remained
statistically constant throughout the same fetal period
Rachedi 1984).

These fetal pancreatic A cells,

morphologically primitive,
L-cells.

(Ali-

although

exhibit similar characteristics as

Changes in cellular gene expression could explain

the declining concentrations of PYY in these cells but more
importantly it suggests that one cell type is capable of
simultaneously translating two gene products

(PYY and

enteroglucagon).
Adrian mapped the distribution of PYY in the
gastrointestinal tract of the pig utilizing radioimmunoassay
(Adrian 1987C).

PYY content was noted to be low in the

foregut and higher in the distal colon.

Peptide

concentrations were 3.4 pmol/g in the antrum;
the mid-duodenum;
100.8 pmol/g.

10.9 pmol/g in

and significantly higher in the ileum,

Similarly,

PYY concentrations increased from

the proximal to distal colon

(pmol/g);

cecum 14.0;

ascending

.
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transverse colon 135.1;

sigmoid 435.0;

descending colon 270.2;

rectum 406.5.

PYY distribution follows a similar pattern in other
mammalian species.

Results have shown that PYY

concentrations are highest in the ileum,

colon and rectum.

Peak concentrations have been reported in the distal colon
while trace amounts have been measured in the stomach,
duodenum and jejunum
1982).

(Adrian 1987b,

Taylor 1985,

Adrian

Miyachi identified the distribution of PYY-like

immunoreactivity in rat tissue utilizing specific RIA
(Miyachi 1986).
colon

The highest concentration of PYY was in the

(298.7-449.5 pmol/g).

These levels were approximately

100-200 times more than that measured in the duodenum.

The

concentration of PYY in the mucosa was higher than that in
the muscular layer in the small bowel,
rectum.

cecum,

colon and

Taylor measured higher levels of PYY in his study

with dogs

(Taylor 1985).

The highest concentration of PYY was

present in the ileum and colon,

1610 and 1607 ng/g

respectively, while lower levels were measured in the
proximal small bowel.
Adrian addressed the question of PYY distribution in
human tissues
specimens,

(Adrian 1985B).

In tissue taken from surgical

PYY was found throughout the small intestines;

duodenum 6 pmol/g;

jejunum 5.0 pmol/g; but highest in the

ileum,

Higher concentrations were measured in the

84 pmol/g.

■
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sigmoid 196 pmol/g.

found exclusively in the mucosal epithelium

PYY was

(Figure 12).

Figure 12: Distribution of peptide YY (PYY) in the human
gastrointestinal tract (picomoles per gram wet
weight of tissue).
From Adrian TE. Gastroenterol
1985; 89:1070-1077.
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DTSTRIBUTION OF NPY
The localization of NPY has been studied using
histochemistry and and radioimmunasssay techniques.

Studies

have shown that NPY has a wide distribution throughout the
body with very high concentrations in the central nervous
system

(Adrian 1983),

(Busch-Sorensen 1989).

demonstrated presense of NPY in the brain

Allen

(Allen 1983)

while

Sasek described NPY-immunoreactivity in the spinal cord
(Sasek 1985).

Others have reported NPY in blood vessels

(Lundberg 1982B),
pancreas,
1983) ,
1984)

heart

genital tract

spleen

(Gu 1984)-

(Lundberg 1982B),

(Lundberg 1985),

and other organs

intestine,

stomach,

lung

(Shepard

adrenal medulla

(Lundberg 1982B).

Ding showed that NPY-

containing nerves were identified in the liver,
and pancreas

(Ding 1991).

(Varndell

Neurologically,

gallbladder

NPY is found to

coexist with other neurotransmitters both centrally and
peripherally

(Carlei 1985,

Everitt 1984).

colocalization of NPY with somatostatin

Emson demonstrated

(Emson 1984)

in the

telencephalon while O'Donohue reported NPY colocalization
with catecholamines in the brain stem
the peripheral nervous system,
colocalized with norepinephrine

(O'Donohue 1985).

In

NPY almost exclusively is
(Ekblad 1984A).

NPY nerves

densely innervate the circular and longitudinal muscle and
myenteric plexus of many organs in the human digestive tract
(Ekblad 1984B,

Furness 1983).

Although NPY has been shown to

colocalize with norepinephrine in the periphery,

Sundler

'
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demonstrated in the gastrointestinal tract that nerve fibers
which contained NPY lacked norepinephrine and that these
nerves originated in intramural ganglia

(Sundler 1983).

The

distribution of NPY throughout the gastrointestinal tract
suggests an important role in the modulation of
gastrointestinal functioning.

RELEASE OF PYY INTO CIRCULATION
The first studies which addressed the release of PYY
into circulation focused on post-prandial release of the
peptide.

Adrian studied the levels of porcine plasma PYY

after the ingestion of a meal

(Adrian 1987B).

Venous levels

of PYY began to rise within the first thirty minutes after
eating and peaking at two hours.

Adrian also demonstrated

some evidence for the metabolism of PYY during its pass
through the liver.

Greeley proposed that cholecystokinin may

mediate the postprandial release of PYY
Taylor,

in canine studies,

(Greeley 1989A).

demonstrated a 205 pmol/liter

increase of plasma PYY levels after intragastric infusion of
a liver extract meal

(Taylor 1985).

Serum PYY concentrations

increased progressively over the two hour study period.
Taylor hypothesized that the delayed peak PYY response to
food could reflect small bowel transit time.
series of experiments,

In his second

Taylor noted that there was no

significant PYY response to insulin hypoglycemia.

This

*
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observation demonstrated that the parasympathetic system does
not play a major role in the release of PYY.
Pappas observed an 86 pmol/liter increase over fasting
levels of plasma PYY following ingestion of a meat meal in
canines

(Pappas 1985).

More interesting however was the

significantly larger rise in plasma PYY levels after infusion
of oleic acid,

403 pmol/liter.

Aponte expanded on the role

of fatty acids and the release of PYY
Utilizing dogs with chronic gastric,
fistulas,

(Aponte 1985).
duodenal and jejunal

fatty acids of varying length,

dodecanoate

(C12)/ were administered.

suspended in a taurocholate solution.

oleate

(C18)

and

The fatty acids were
He demonstrated that

PYY release was not dependent on length of fatty acids.
However,

Aponte failed to evoke an increase in PYY

when

fatty acids were infused into the stomach or duodenum.

Only

by instilling the fatty acids into the distal gut did he
demonstrate

release of PYY.

It is therefore apparent that

there are at least two mechanisms involved in the release of
PYY from the gut:

a moderate post-prandial response as well

as a second more potent release following the direct
instillation of fatty acids and bile salt into the colon.
Longo similarly reported a release of PYY in the isolated
rabbit colon after infusion of short chain fatty acids

(Longo

1991) .
Adrian documented the release of PYY in human subjects
(Adrian 1985D).

Utilizing 25 healthy human subjects,

PYY
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levels were recorded during a fasted state as well as after
various caloric meals.
pmol/liter.

Fasting plasma PYY levels were 8.5

After the administration of a 530 kcal meal,

this level rose 3.7 pmol/liter.

Similarly,

an 870 and 4500

kcal meal caused significant increases in plasma PYY levels,
16.2 and 45.0 pmol/liter respectively.
Greeley compared the effects of various nutrients
proteins,

amino acids,

and carbohydrates)

(fats,

given directly into

the duodenum or the colon on the release of PYY in conscious
dogs

(Greeley 1989B).

Although intraduodenal administration

of an amino acid mixture,

glucose or liver extract failed to

elevate plasma levels of PYY,

intracolonic administration of

these nutrients significantly stimulated PYY release.

The

study suggested that unabsorbed nutrients can release PYY by
direct contact with the PYY-containing cells of the terminal
ileum,

colon and rectum.

Ballantyne demostrated that deoxycholic acid is a potent
agent for stimulating the release of PYY from the isolated
perfused rabbit left colon.

These findings suggest that the

arrival of bile salts into the colon may play an important
part in a feedback system whereby the colon participates in
regulating proximal gastrointestinal function

(Ballantyne

1989) .
These studies have therefore demonstrated that PYY is
released into the systemic circulation in response to normal
feeding patterns in humans and mammalian systems.

It has
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also been demonstrated that there is an even greater release
of PYY following instillation of fatty acids suspended in
bile salts directly into the distal bowl.

In addition,

although the mechanism of release of PYY is incompletely
understood,

it does not appear to be vagally mediated.

NPY RELEASE
NPY is released with norepinephrine in response to
sympathetic nerve stimulation

(Lundberg 1982D).

Sheikh

demonstrated electrical stimulation of the splanchnic nerve
supply to the isolated perfused pig pancreas resulted in the
co-release of NPY and noradrenaline into the venous effluent
(Sheikh 1988).

Stimulation of the vagus nerve caused a

substantial release of NPY without altering levels of
noradrenaline.

This release of NPY can be blocked by

guanethidine in the cat spleen and is facilitated by alpha-2adrenoceptor blocking agents in the dog spleen
1984,

(Lundberg

Schoups 1988).

PYY IN GASTROINTESTINAL PHYSIOLOGY
The effects of PYY on gastrointestinal physiology have
been extensively studied.

Although PYY is found in highest

concentrations in the terminal ileum,

colon and rectum,

the

major effects of the peptide include inhibition of gastric
acid and pancreatic secretion,
motility,

gastric and intestinal

and the release of insulin and glucagon.
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In human studies, Adrian demonstrated that PYY

inhibits gastric acid secretion

(Adrian 1985A).

Human

subjects were given a continuous infusion of PYY,
pmol/kg/min,

0.2

sufficient to cause an increase in plasma PYY of

27 pmol/liter.

Pentagastrin stimulated gastric acid and

pepsinogen output were decreased by 77% and 96%,
respectively.

The incremental gastric volume response

decreased by 90%.

Pappas evaluated the effect of PYY on meal-

stimulated gastric and pancreatic secretion in dogs
1985).

(Pappas

Pancreatic protein secretion and gastric acid

secretion were significantly inhibited by PYY infusion at a
rate of 400 pmol/kg/hr.
Pancreas:

The role of PYY on pancreatic exocrine

function has also been evaluated.

Tatemoto demonstrated in

the anesthetized cat that a bolus injection of 100-200
pmol/kg PYY caused a 70-80% reduction of pancreatic secretion
of fluid and bicarbonate following both secretin and
cholecystokinin stimulation of the pancreas

(Tatemoto 1982B).

Adrian performed studies in which PYY failed to inhibit
pancreatic secretions in human

(Adrian 1985D).

Although

Adrian demonstrated that low dose PYY inhibited gastric acid
and pepsin secretion,

there was no effect on the secretion of

pancreatic bicarbonate or trypsin,

or duodenal juice

following low-dose secretin and cholecystokinin-8
stimulation.

,
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Szecowa demonstrated that PYY did not have any effects
on pancreatic endocrine function
anesthetized rats,

(Szecowa 1983).

In

PYY was infused at a dose of 100

pmol/kg/min to elevate plasma levels well above normal
physiologic levels.

At this high dose,

on basal insulin and glucagon levels.

there was no effect
Similarly,

there was

no observed change in glucose-induced insulin release from
pancreatic islet cells.
Several reports stated that PYY exerts its inhibitory
effect of pancreatic secretion via an activation of an
adrenergic pathway.

Konturek demonstrated that PYY inhibits

pancreatic secretion only in vivo but not in vitro isolated
pancreatic acini after administration of the alpha-receptor
antagonist phentolamine and the beta-receptor antagonist
propranolol

(Konturek 1986).

Pawlik reported that in a

series of 22 anesthetized canines,

phentolamine and

propranolol blocked the the action of PYY on secretin-induced
pancreatic secretion.

In addition,

the antisecretory

activity of PYY was partially blocked by total bilateral
adrenalectomy

(Pawlik 1986).

Gallbladder:

Further studies evaluated the role of PYY

in gallbladder function.

Grace demonstrated that PYY

significantly inhibited CCK-stimulated sphincter of Oddi
phasic wave frequency and motility index
However,

(Grace 1988).

gallbladder contractions were unaffected.

canine model,

In a

the common bile duct was canulated and PYY
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infused in graded doses from 100-400 pmol/kg/hr.

When

intraduodenal administration of hydrochloric acid was
performed,

the bile flow rate increased but the total output

of the bile salts remained unchanged
studies,

Adrian demonstrated that low-dose PYY,

pmol/kg/min,
duodenum,

In human

0.62

had no effect on bilirubin output in the

following low dose secretin and cholecystokinin-8

stimulation

(Adrian 1985D).

Vasculature:

PYY is also known to demonstrate

vasoconstricting properties.
model,

(Gomez 1986).

Utilizing an anesthetized cat

Lundberg demonstrated that electrical stimulation of

the cervical trunk resulted in submandibular salivary
secretion and vasoconstriction

(Lundberg 1982C) .

The

vasoconstricting properties of PYY were still present after
alpha-receptor blockade as well as in sympathectomized
animals.

Infusions of PYY,

pancreatic polypeptide

(PP)

neuropeptide Y

(NPY)

as well as

resulted in a vasoconstriction

similar in nature to that of the adrenergically blocked
electrically stimulated response,
duration

(Lundberg 1982D).

noradrenaline
peptide

These results suggest that

(fast response)

(slow response)

these vascular nerves.

slow in onset and long in

coupled with a PP-related

might be the transmitters involved in
In addition,

PYY and these peptides

elevated systemic blood pressure during these experiments.
This is presumed to be a result of systemic vasoconstriction.
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significantly elevated levels of PYY and NPY might act

directly on the vascular smooth muscle

(Vukasin 1989).

Lundberg demonstrated that PYY had marked vascular
effects in the gastrointestinal tract

(Lundberg 1982A).

Close intraarterial administration of PYY

(25-150 pmol/kg)

in

cats caused an intestinal vasoconstriction as well as an
increase in systemic blood pressure.

These effects were

reproducable even with pretreatment with an adrenergic
blocking agent.

Adrian studied the hemodynamic effects of

infused PYY into human volunteers

(Adrian 1986B).

During

infusion periods, plasma PYY levels increased 73 pmol/liter
more than basal levels.

There was a significant increase in

both systolic and diastolic blood pressure,
mmHg respectively.

8.6 mmHg and 10.9

These studies further support the

hypothesis that significantly elevated levels of PYY may act
directly on vascular smooth muscle leading to contraction and
elevation of systemic blood pressure
Motility:

(Vukasin 1989).

PYY has significant and profound effects on

gastric emptying and bowel motility.

Lundberg demonstrated

that both jejunal and colonic motility were inhibited by
intraarterial infusion of PYY

(Lundberg 1982A).

The

inhibition of motility was most pronounced in the colon,
lasting for nearly one hour after cessation of PYY infusion.
Suzuki investigated the effect of PYY on gastric contractile
activity in Heidenhain pouch dogs

(Suzuki 1983).

PYY was

given in an intravenous bolus with doses ranging between 12.5

/'
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PYY had no effect on contractile activity

in the stomach during the digestive state.
interdigestive state,

PYY,

However,

in the

in a dose-dependent manner,

inhibited the interdigestive migrating contractions in the
innervated main stomach but did not affect the motor activity
in the pouch.

This supports the hypothesis that PYY exerts

its effects through the extrinsic nerves.

Al-Saffar

evaluated the effect of PYY on the myoelectric activity of
the small intestine in conscious rats
Following intravenous infusion,

PYY

(Al-Saffar 1985).

(50 pmol/kg/min)

had no

effect on the occurence of the migrating myoelectric complex
in the duodenum but interrupted its distal propagation and
almost abolished total spike activity in the jejunum.

The

rats were additionally given a sicr labelled marker and it was
observed that its transit was significantly delayed in those
given PYY.

Al-Saffar suggested that inhibition of the

activity front by PYY may account for the delay in small
bowel transit in those rats receiving PYY

(Vukasin 1989).

Several studies reported the effects of PYY on
gastrointestinal motility in humans.
intravenous PYY

(2 pmol/kg/min)

Allen administered

to achieve a plasma level of

59 pmol/liter, which significantly delayed gastric emptying
(Allen 1984).
(PYY)

Savage evaluated the effects of peptide YY

on mouth-to-cecum intestinal transit time and on the

rate of gastric emptying in healthy adults
Subjects were given two doses of PYY,

(Savage 1987).

the lower dose 0.18
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pmol/kg/min,

mimicking the post prandial

higher dose,

0.51 pmol/kg/min,

state while the

representing a malabsorptive

state.

Gastric emptying was prolonged from 37 minutes to 63

minutes

for the

of PYY.

low dose and to 130 minutes

for the high dose

Mouth-to-cecum transit time was delayed from 67

minutes to 94 minutes

for the low dose and to 192 minutes

for

the high dose of PYY.
Secretion•

PYY may also play an important role

regulation of chloride transport

in the small bowel.

application of PYY decreases basal
rat

jejunal and colonic mucosa.

that

reported that

PYY also

Serosal

short circuit current

in

36cl-flux studies indicate

this drop in short circuit current results

inhibition of chloride secretion

in the

(Cox 1988A).

from the
Playford

inhibited VIP-stimulated secretion in

healthy human volunteers

(Playford 1990).

NPY.. ...IN GASTROINTESTINAL.PHYSIOLOGY
Many NPY-containing enteric neurons of the gut
the epithelial cells of the intestinal mucosa
Friel

innervate

(Furness

1983).

first reported that NPY may play an important role as a

powerful modulator of

epithelial

ion transport

(Friel

1986).

Researchers have demonstrated that NPY inhibits carbachol,
VIP,

substance-P,

and prostaglandin E2-stimulated chloride

secretion in rat jejunum
a study with rabbits,
chloride absorption

(Cox 1988B,

Saria 1985).

Hubei,

in

demonstrated that NPY increases ileal

(Hubei 1986).
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The colocalization of NPY and vasoactive intestinal
peptide

(VIP)

in neurons that innervate intestinal epithelia

led researchers to believe that NPY down-regulates VIPstimulated ion transport through direct effects on the
colonic enterocytes.

Indeed,

Flint demonstrated that when

NPY was administered to the basolateral membrane,

there was

inhibition of VIP-stimulated short-circuit current changes by
a tetrodotoxin-insensitive mechanism

(Flint 1990).

Hellstrom demonstrated that intraarterial infusion of
NPY in the anesthetized rat caused a decrease in measured
colonic motility

(Hellstrom 1985).

Allen reported that NPY

inhibited contraction of longitudinal ileal nonvascular
smooth muscle in vitro

(Allen 1987).

In the study,

NPY

inhibited both spontaneous contractions and also reduced
amplitude of neurally mediated contraction of longitudinal
smooth muscle elicited by electrical stimulation of the
intramural nerve plexuses.

Wiley reported that NPY caused a

dose-dependent relaxation of guinea pig colon longitudinal
muscle

(Wiley 1987).

This relaxation occured via release of

norepinephrine with subsequent inhibition of acetylcholine
release.

Norepinephrine,

the myenteric plexus,

located in sympathetic nerves in

inhibits cholinergic transmission via

alpha-2-receptors located on postganglionic cholinergic
nerves.
Researchers have also focused on the role of NPY on
mammalian sphincter control.

Ferri demonstrated the presense
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of NPY in the intramural neurons of the internal anal
sphincter of humans

(Ferri 1988).

NPY was shown to

colocalize with VIP-containing nerve fibers in this region
(Wattchow 1988).

Nurko examined the role of NPY in the

opossum internal anal sphincter

(Nurko 1990).

He determined

that NPY acted directly on internal anal sphincter smooth
muscle to increase sphincter pressure.

It also inhibits

relaxation of the sphincter produced by the rectoanal reflex.

CHANGES IN PLASMA LEVELS OF PYY IN STATES OF PATHOPHYSIOLOGY
Researchers have demonstrated altered plasma levels of
PYY in various pathophysiologic states in addition to several
post-surgical states of the gastrointestinal tract.

Adrian

examined the release of PYY following ingestion of glucose in
patients with the dumping syndrome,
gastrectomy and gastrojejunostomy

a complication of

(Adrian 19850.

The

dumping syndrome is thought to be caused by the rapid transit
of hyperosmolar chyme into the jejunum,

followed by an

osmotically driven fluid rush into the small bowel depleting
intravascular volume,
symptomatology.

and hence,

the cause of much of its

Vasoactive intestinal peptide or neurotensin

may be involved in the etiology of the disorder
1980,

Sagor 1981).

(Blachburn

Adrian administered 100 grams of glucose

to patients and measured plasma PYY levels.

Plasma PYY

levels in the control patients increased by 3.4 pmol/liter,
while those in patients with dumping syndrome increased by 65

„
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The effect of PYY was completely abolished by

the intravenous administration of somatostatin,

a paracrine

regulator present in endocrine cells throughout the
gastrointestinal tract

(Vukasin 1989).

Plasma PYY levels are also altered after various
gastrointestinal surgical procedures

(Ballantyne 1990).

Savage demonstrated that plasma PYY levels were increased in
rats who underwent 75% proximal small bowel resection
1985).

Preoperatively,

(Savage

plasma levels averaged 28 pmol/liter

and levels rose to 85 pmol/liter six days postoperatively.
Levels were consistently elevated for 48 days.

Adrian

reported plasma PYY levels in a series of human subjects who
had undergone resection of small bowel,

colon or pancreas

(Adrian 1987a).

In 18 patients who had undergone partial

ileal resection,

basal PYY levels were greatly elevated as

compared to control.

However,

in 16 patients who underwent

colonic resection and ileostomy,
significantly lower.
pancreatectomies,

PYY levels were

In eight patients who had undergone

the plasma levels of PYY were only

moderately increased.

The elevated levels of PYY in patients

with pancreatectomy and ileal resection could be attributed
to a release of PYY in response to increased bile salts,
fats,

or other nutrients reaching the distal bowel.
The "ileal brake" mechanism of small intestinal motility

refers to the slowing of gastric emptying and small bowel
transit following infusion of nutrients into the ileum.

1
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Small intestinal resection prompts adaptive changes which
slow intestinal motility and increase mucosal absorptive
capacity.

Circulating levels of PYY increase following small

intestinal resection.

This slowing effect of gut transit

following meals has been termed the "ileal brake" effect
(Spiller 1984, Macfarlane 1983,

Hill 1974).

Armstrong

reported an adaptive increase in PYY after proctocolectomy
and pelvic ileal reservoir construction in dogs

(Armstrong

1991) .
Large bowel resection leads to a reduction of plasma
levels of PYY.

This lack of hormonal adaptation may be due

to the loss of hormone secreting cell mass

(Adrian 1987C)

and

has been implicated in the etiology of post-colectomy
diarrhea.

In addition,

combined large bowel resection and

ileal resection results in watery diarrhea which is
disporportionally profuse considering the short lengths of
ileum resected

(Neal 1984).

This may result from the loss of

the "ileal brake."
Similarly,

PYY levels are significantly augmented in

various gastrointestinal disorders.

Adrian reported plasma

PYY levels in patients with various gastrointestinal diseases
(Adrian 1986A).

Patients with steatorrhea due to tropic

sprue had significantly elevated plasma PYY levels after a
meal.

Basal levels in these patients were reported to be 10-

times higher than in their control population.

Similarly,

patients with steatorrhea due to chronic destructive

.
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pancreatitis had increased basal and postprandial levels of
PYY.

In patients with inflammatory bowel disease,

a moderate elevation of PYY levels.

there was

Sjolund reported that

plasma PYY levels were increased in patients with celiac
disease.

In addition,

he demonstrated that these abnormal

levels were inversely proportional to the concentration of
plasma folic acid concentrations.

Adrian proposed that PYY

levels were elevated in patients with disoders of
malabsorption.

The presence of abnormal bowel contents

reaching the distal colon may cause release of PYY.

PYY

would likely assuage the symptoms of these disorders by
delaying gastric emptying as well as small bowel motility
leading to increased proximal absorption.

PYY AND NPY RECEPTORS
Cell surface receptors for PYY have been characterized
but the number,

distribution and classification of these

receptors remain under intense investigation.

To date,

exists at least four distinct NPY/PYY receptors,
Yl,

Y2,

Y3 and Y4.

designated

High affinity receptors for PYY were

first identified on rat jejunal epithelial cells
1986).

there

(Laburthe

The receptor bound both NPY and PYY but had a five¬

fold higher affinity for PYY.

The distribution of PYY is not

uniform within the intestinal mucosa.

Studies have shown

that the PYY-preferring receptor is found in greater number
on the crypt cells than on the mature villus cells

(Voisin

'
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Mannon demonstrated that the greatest density of PYY

receptors in the rabbit was in the descending colon

(Mannon

1991) .
PYY and NPY may bind the same receptors.
reported distinct receptors for NPY and PYY,
and Y2

(Sheikh 1989A).

distinct.

Sheikh
designated Yl

These receptors are pharmacologically

Wahlestedt reported evidence for different pre-

and post-junctional receptors for NPY and PYY
1986, Wahlestedt 1990).

(Wahlestedt

In various animal studies,

he

demonstrated that NPY and PYY exerted three distinct effects
at the level of the sympathetic neuroeffector junction.
and PYY had a direct post-junctional effect,
constriction of certain blood vessels.

NPY

leading to

Secondly,

they

potentiated the response to various vasoconstrictors.
Finally,

NPY and PYY were demonstrated to act pre-

junctionally to suppress the release of noradrenaline from
sympathetic nerve endings in stimulated rat vas deferens.
The distinction between Yl and Y2 is based on the Cterminal fragment of these peptides.

Sheikh demonstrated

that the Y2 receptor binds the long COOH-terminal fragment of
NPY or PYY

(amino acids 13-36)

(Sheikh 1989B).

is unable to bind to the Yl receptor.

This fragment

Fuhlendorff,

study utilizing human neuroblastoma cell lines,

in a

classified a

specific Yl receptor in which two critical amino acid
substitutions have been made
compound,

[Leu31,

(Fuhlendorff 1990A).

This

Pro34]NPY displaced radiolabelled NPY only
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from cells that expressed Yl receptors and not those
expressing Y2 receptors

(Figure 13).

Further work by Sheikh

structurally characterized these receptors for NPY and PYY by
affinity cross-linking

(Sheikh 1990).

Their results

indicated that the Yl receptor is a glycoprotein with an Mr =
70,000 binding subunit, whereas the Y2 receptor is a
glycoprotein with a Mr = 50,000 binding subunit.

The study

demonstrated that the Yl and Y2 receptor subtypes are
structurally distinct glycoproteins,
other subunits.

not disulfide-liked to

Fuhlendorff further determined that position

34 on the peptide was critical for specific binding
(Fuhlendorff 1990B).

The antiparallel pancreatic-polypeptide

fold present in NPY and PYY is of structural importance for
the receptor binding.

This fold allows presentation of the

carboxyl- and amino-terminal segments of the peptide to the
receptor.
Y3 receptors can be activated by NPY but not PYY and may
mediate cardiovascular responses
1991,

Sheriff 1990).

investigated

(Baranowska 1987,

Grundemar

Other receptor subtypes are still being

(Wahlenstedt 1992).

A receptor with equal

affinity for PYY, NPY and PP was detected on rat pancreatic
islet and acinar cells,
the stomach,

hepatocytes and epithelial cells of

duodenum and small intestine

(Nata 1990) .

Y4 receptor has only recently been characterized.

The

Ballantyne

has demonstrated a receptor which shows the same affinity for
NPY,

PYY and PP as well as the same efficacy.

Activation of
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this receptor blocks vasoactive intestinal peptide-stimulated
chloride secretion from the colon

(Ballantyne 1993).

Neuropeptide Y
VPSKPDNPGEDAP AEDLARYYSALRHYINLITRQRY?0
[Leu 31 .Pro 341NPY
YPSKPDNPGEDAP AEDL ARY YSALRHY I NLtSTR0RY:°
i

i

i

i

i

i

'•'j

Pancreatic polypeptide
APLEPVYPGDNATPEQMAQY AADLRRYINMLTRPRY:0
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Figure 13:Diagram of the structure of [Leu31,Pro34]NPY and
the aligned sequences of NPY, [Leu31,Pro34]NPY, and
PP.
The schematic structure of the NPY analog
shown at the top was based on the x-ray structure
of avian PP.
From Fuhlendorff J.
PNAS (USA) 1990;
87:182-186.
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it was believed that the Y2 receptor was localized

presynaptically while Yl was confined postsynaptically but
studies have demonstrated the presence of Y2 receptors on
renal proximal tubule cells suggesting that this scheme may
be overly simplified.

MECHANISMS-QF ..ACTION OF PYY AND NPY
Although the exact mechanisms of action of both PYY and
NPY are incompletely understood in gastrointestinal
physiology,
peptides:

there are three possible actions of these
1)inhibition of cAMP formation;

cytosolic levels of calcium;

2)increase of

and 3)mobilization of

intracellular calcium.
Research has demonstrated that both PYY and NPY cause
hydroelectrolytic absorption and inhibit vasoactive
intestinal peptide

(VIP)

and prostaglandin E2-induced

secretion in the small bowel in vivo and in vitro
1985, MacFadyen 1986,

Friel 1986,

Cox 1988A).

(Saria

VIP and

prostaglandin E2 are both potent secretagogues that act via
increase in cAMP levels.

Servin demonstrated that PYY and

NPY inhibited VIP-stimulated cAMP production in epithelial
cells isolated from rat intestines

(Servin 1989).

PYY also inhibited prostaglandin E:-,

NPY and

prostaglandin E2-,

and

foskolin-stimulated cAMP production and reduced basal cAMP
levels.

These effects were confined to the small bowel.

1
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Further studies have demonstrated that NPY and PYY inhibited
basal and forskolin stimulated adenylate cyclase activity
(Westlind-Danielsson 1988).
Studies suggest that PYY may act through a pertussis
toxin-sensitive G protein

(Kassis 1987, Motulsky 1988).

Valet demonstrated that PYY and NPY inhibited cAMP dependent
lipolysis in both canine and human adipocytes through
specific receptors coupled negatively with adenylate cyclase
by a pertussis toxin-sensitive protein

(Valet 1990).

Additionally,

specifically bound to

Lobaugh showed that NPY

a G protein-linked receptor that inhibits adenylate cyclase
in human neuroepithelioma cells

(Lobaugh 1990).

The role of calcium mediated processes in the actions of
NPY and PYY is still under investigation.

The effects of NPY

on intracellular calcium levels has been partially defined
whereas knowledge of PYY's effects remain incompletely
understood.

The mobilization of calcium can occur via influx

of extracellular calcium or through mobilization on
intracellular stores.

NPY stimulates vasoconstriction as

well as enhances the release of calcium channels
(Pernow 1987,

Lundberg 1988,

Crowley 1990).

(L-channels)

NPY decreases

the release of acetylcholine from rat nodose neurons by
inhibiting gadolinium sensitive calcium channels
channels)

(N calcium

through a pertussis toxin-sensitive mechanism

(Wiley 1990).

Effects of NPY on voltage dependent calcium

channels may also be indirect.

Shangold proposed that NPY

.
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may inhibit calcium entry through L channels by enhancing a
hyperpolarization K+ conductance

(Shangold 1989).

Present

studies support the hypothesis that NPY may modulate influx
of extracellular calcium via actions on either L-,

or N-type

calcium channels in different cell types.
Other actions of NPY appear independent of extracellular
calcium

(Sabatino 1989).

In human neuroblastoma cells which

only express the Yl receptor,
36)

[Leu31,

Pro34]NPY but not NPY(16-

causes a transient elevation of intracellular Ca++

(Aakerlund 1990).

This effect is independent of

extracellular calcium,

is blocked by thapsigargin which

selectively depletes calcium stores in the endoplasmic
reticulum

(Thastrup 1989),

and is pertussis toxin-sensitive.

Jackson demonstrated that the calcium pool affected by
thapsigargin is inositol 1,4,5-triphosphate-sensitive
(Jackson 1988).

These studies suggest that when NPY binds Yl

receptors a transient calcium signal is produced through
mobilization of calcium from stores in the endoplasmic
reticulum and that this effect is mediated by a G protein and
a generation of inositol 1,4,5-triphosphate.
Some of the actions of PYY may result from the
inhibition of the release of other regulatory peptides.

PYY

may inhibit sham feeding-stimulated acid secretion by
blocking acetylcholine release from vagal fibers
1986).

(Pappas

The effects of PYY on pancreatic secretion may derive

from the inhibition of cholecystokinin release

(Lluis 1988,

>v
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PYY inhibits acetylcholine release from

nerves in the guinea pig stomach

(Wiley 1991).

Also,

PYY

inhibition of cholecystokinin stimulated contractions of
ileal muscle strips may stem from the inhibition of
acetylcholine release from cholinergic nerves

(Baba 1990).

Thus the effects of PYY in vivo are complex and result from
cascade of direct and indirect actions.

FERZOCO,

METHODS -113-

SJ

METHODS
ISOLATED PERFUSED RABBIT ILEUM
rabbits
HCl

(3-4 kg)

(50 mg/kg)

New Zealand white

were anesthetized with subcutaneous ketamine

and xylazine

(20 mg/kg).

Intravenous fluids

(0.9% NaCl) were administered through a lateral ear vein to
maintain stable heart rate,

blood pressure and urine output.

Preoperatively,

heparin

intravenously.

The abdomen was entered via a midline

incision.

(2000 units) was injected

The ileocolic artery and vein were then identified

as well as the terminal ileum.

The ileocolic artery was then

cannulated with a standard 20 guage intravenous catheter
Cathlon,

Critikon,

Tampa,

Florida).

immediately perfused with warmed
C02)

The artery was

(37°C) ,

Krebs Ringer's Bicarbonate solution

4.7 mM,
0.12 mM,

CaCl2 2.5 mM, MgCl2 1.3 mM,
dextrose 5.6 mM,

rate of 3 ml/min.
are ligated.

(20G

oxygenated

(95% 02/5%

(NaCl 118.4 mM,

NaHC03 23.4 mM,

KCl

NaH2P04

bovine serum albumin 30 (1M)

at a

Perfusion was initiated before the vessels

Consequently,

there was no period of ischemia.

A 10 cm segment of terminal ileum based on the cannulated
vasculature was harvested.

The margins of the mesentery were

ligated and divided so as to avoid loss of perfusate.

The

organ was then placed on a warmed humidified organ plate
(Nigel Cox,

Yale Instrumentation Shops,

the end of the operation,

New Haven,

CT).

At

the rabbits were euthanized with an
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additional ketamine bolus
saturated KC1 solution
ORGAN VIABILITY

(200 mg/kg IV)

followed by a

(5 ml IV).
Organs were examined by light

microscopy to ensure structural integrity. At the termination
of experiments tissue samples from the perfused segments of
small bowel were preserved in formalin and subsequently
embedded in paraffin,
and eosin.

sectioned and stained with hematoxylin

In addition,

serial arterial and venous blood

gases were obtained at hourly intervals for the duration of
the experiments.

pH,

pC02,

and p02 were measured with a

clinical grade Corning 168 pH/Blood Gas Analyzer
Medical & Scientific,
MOTILITY

Medfield, MA).

Motility of the perfused segment of ileum was

measured by insertion of a multilumen
catheter

(Corning

(J.S.

Biomedicals,

Ventura,

(4 port)
CA.)

manometry

into the gut lumen.

The manometer ports were spaced at 2.5 cm intervals and
perfused at a constant pressure of 15 cm H20 with distilled
water

(a total volume of 3 cc/min).

The manometer catheter

was linked to pressure transducers which were interfaced to a
polygraph

(Narco Biosystems MMS 200,

Houston,

TX.)

The

analog signal was then digitalized at a rate of 8 data points
per second and stored on a computer hard disc
2,

Model 70,

386)

(IBM PC System

for subsequent statistical analysis.

Motility was quantified by the integration of the area under
the digitalized pressure-time curve for one minute intervals
using computer software

(Narco MMS,

Houston,

TX.)

Mean
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activity in all four channels was used to quantitate
motility.

Results were expressed in units of mmHg.min.

STATISTICAL ANALYSIS

For each test agent,

the

integrated response during the stimulated period was compared
to the resting period and the recovery period using Student's
t-test for paired samples.

Integrated responses of groups of

test agents were compared by testing the homogeneity of
variances using Bartlett's test.

When a significant F value

results from the analysis of variance

(p<0.05),

the Tukey

test was applied on the means of the integrated response of
the test agents ranked in order of magnitude.

All data

analysis was performed using a computer software package.
EXPERIMENTAL DESIGN

Each concentration of test agent or

control was tested in four individual colon preparations
4).

In each preparation,

(N =

the isolated ileum was allowed a

ten minute recovery period,

during which it was maintained on

the organ perfuser with no intraluminal stimulation.
Intraluminal test agents were then infused through the
arterial side at a rate of 0.3 ml/min.

Infusions of various

test agents ranged from 5 to 90 minutes.

Prokinetic agents

were infused at a constant rate and concentration for ninety
minute time periods.
10 minutes.

Inhibitory agents were infused from 5-

Experiments with pancreatic polypeptide-fold

family analogs

(NPY,

PYY or PP)

required pretreatment of the

appropriate test agent for five minutes prior to
administration of the inhibitory agent

(Figure 14).

■
-
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MATERIALS

The following chemicals and agents were

obtained from Sigma,
NaHC03,

NaH2P04,

xylazine,

St. Louis, MO:

dextrose,

and forskolin.

naloxone,

KCl,

bovine serum albumin,

formalin, paraffin,

tetrodotoxin,

NaCl,

hematoxylin,

atropine,

Cholecystokinin,

CaCl2,

MgCl2,

ketamine HCl,

eosin,

carbachol,

norepinephrine

the cholecystokinin

antagonist L364,718, motilin, vasoactive intestinal peptide,
peptide YY,

neuropeptide Y,

[Leu31, Pro34]NPY and NPY
Laboratories,

Inc.,

pancreatic polypeptide,

(13-36) were obtained from Peninsula

Belmont,

CA.
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A)

Basal

Prokinetic agent

time

Test Agent
VIP
Prokinetic agent

time
Figure 14:
These figures represent the experimental protocol.
After isolation of the segment of terminal ileum, the organ
is allowed a brief recovery period prior to measurement of a
baseline level of motor activity.
The specific prokinetic
agent tested is then infused at a constant concentration and
rate (A).
In those experiments in which a test agent is used,
infusion of the appropriate test agent begins five minutes pri
to administration of the prokinetic antagonist, in this case
VIP (B).
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ORGAN VIABILITY
After 90 minutes of perfusion on the whole organ
apparatus,

sections of tissue from the experimental ileum

were collected for histological evaluation.

Subsequently,

these tissues were stained with hematoxylin and eosin for
light microscopy.

Cellular architecture and integrity of the

ultrastructural features remained intact during this period
(Figure 15).

However,

there was some interstitial edema

present.
Oxygen and carbon dioxide tensions in the arterial and
venous fluids were consistent with normal metabolic activity
within the isolated organ preparation.

At no time did the

arterial P02 fall below 100 mm Hg or the venous C02 exceed 35
mm Hg

(Table 1).

ILEAL MOTILITY
Unstimulated motility in the isolated ileum was
evaluated.

After a brief latency period,

motility reached a stable plateau:

resting ileal

41.3±2 mmHg/min.

There

were no statistically significant changes of resting ileal
motility for 90 minutes of recording

(Fig 16).

All

subsequent experiments were therefore limited to ninety
minute test periods.
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Figure 15: Hematoxylin and eosin section (x 20) of rabbit
terminal ileum after 90 min of perfusion on an
isolated organ platform.
The smooth muscle and
mucosa appear viable.
Some interstitial edema is
present.
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2 HOURS

3 HOURS
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ARTERIAL

VENOUS

PH

7.46 ± 0.024

7.29 ± 0.05

C02

17.6 ± 1.1

17.4 ± 1.4

02

320 ± 34

131 ± 13

PH

7.43 ± 0.06

7.44 ± 0.02

C02

19.1 ± 2.3

23.0 ± 3.2

02

223 ± 37.4

170 ± 19.8

PH

7.46 ± 0.041

7.46 ± 0.056

C02

22.3 ± 4.5

22.2 ± 1.8

02

191.6 ± 19.8

106 ± 3 .7
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MOTILITY (mmHg.min)

FERZOCO,

Figure 16: Baseline motor activity of unstimulated segment of
terminal ileum after 90 minutes of perfusion.

FERZOCO,

SJ

PROKINETIC

RESULTS

-122-

AGENTS

CARBACHOL
The effect of carbachol on ileal motility was tested.
Carbachol

(10-8-10-5M)

infusion caused a concentration-

dependent increase in phasic motor activity with an ED50 of 107M

(Figure 17)

Carbachol-induced motility values remained

stable for more than 90 minutes

(Figure 18).

All other

experiments which utilized a continuous infusion of carbachol
were limited to less than 90 minutes

Unstimulaled

10 8 M

10-,M

10 8 M

(Table 2).

10 5 M

CARBACHOL

Figure 17: Action of carbachol on isolated, perfused ileum.
Carbachol infusion resulted in phasic ileal
contractions.
A concentration-dependent increase
in motor activity was seen with an ED50 = 10-7 M
(inset).
n = 4 for each group.

FERZOCO,

SJ

RESULTS

-12 3-

Figure 18: Pressure recording of motor activity for
unstimulated and carbachol (10-7 M) treated ileum
over a 90-minute time period.
After a 10-minute
equilibrium period, motor activity for both
unstimulated and carbachol-stimulated preparations
remained essentially unchanged for the duration of
the experiment, n = 4 for each group.
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CARBACHOL-STIMULATED INCREASE OF MOTOR ACTIVITY IN

ISOLATED PERFUSED SEGMENTS OF RABBIT TERMINAL ILEUM

CARBACHOL

BASELINE

10-8 M

10-7 M

10-6 m

41+2

88+8* *

312+6*

1006+38*

*

P <

0.05 COMPARED TO BASELINE VALUES.

10-7 M

984+40*
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C HQ L EC Y.STDK ININ
CCK

(10-9-10-7 M)

motility

(Figure 19).

infusion resulted in an increase in
This phasic pattern of motor activity

was unaffected by tetrodotoxin

(lO6 M)

or naloxone

(10-5 M)

but was inhibited by atropine

(10-5 M)

L-365,718

CCK-induced motility remained

(IO-9 M)

(Table 3).

stable for greater than 90 minutes

and the CCK antagonist

(Figure 20).

All other

experiments which utilized a continuous infusion of CCK were
limited to less than 90 minutes.

Figure 19: Effect of cholecystokinin on isolated segment of
rabbit terminal ileum.
Cholecystokinin, a
naturally occuring peptide in the gastrointestinal
system, resulted in phasic ileal contractions.
A
concentration-dependent increase in motility was
seen with an ED50 of IO
M (inset) .
n = 4 for each
group.
-9
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TABLE 3.

EFFECTS OF TETRODOTOXIN,

ATROPINE AND L364,718 ON

CCK STIMULTED MOTILITY

CCK ALONE
TETRODOTOXIN

(10 "6M,

(10-5M,

ATROPINE
L3 64,718

10^1 M

10^1 M

1187+44

1113+44

479+14

n=5)

524+43
484+18

(10_5M,

243+121

(10-9M,

n=3)

114+40*

ii

n=4)
G

NALOXONE

ljQ-2L_M

* P < 0.05 COMPARED TO CCK

(10-9M)

ALONE
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TIME (min)

Figure 20: Pressure recording of motor activity for
unstimulated and cholecystokinin (10-9 M) treated
ileum over a 90-minute time period.
After a 10minute equilibrium period, motor activity for both
unstimulated and cholecystokinin-stimulated
preparations remained essentially unchanged for the
duration of the experiment, n = 4 for each group.
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MOTILIN
Motilin

(10-10-10-7 M)

caused a concentration-dependent

increase in measured motor activity in isolated segments of
perfused terminal ileum

(Figure 21).

Phasic motor activity

was similar to those of other prokinetic agents.

Motor

activity remained stable for the duration of infusion and
returned to preinfusion levels with the cessation of motilin
administration.

MOTILIN

MOT 108

Figure 21: Action of motilin on isolated, perfused terminal
ileum.
Motilin infusion resulted in phasic ileal
contractions.
A concentration-dependent increase
in motility was seen with an ED50 of 10-8 M (inset)
n = 4 for each group.

i
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VIP INHIBITION
To determine the effects of cAMP dependent agents on
intestinal motility,

vasoactive intestinal peptide was tested

against various prokinetic agents.

VIP

(10-9-10-7M)

concentration dependent inhibition of carbachol
stimulated motility after a brief latency

caused a

(10-7 M) -

(Figure 22).

This

inhibition was reversible after the cessation of VIP
administration.

The half-effective dose

(ED50)

for VIP was 10-

8M.

10'® M

10*M

ia7M

VASOACTIVE INTESTINAL PEPTIDE

4
VIP 10 8 M

VIP OFF

Figure 22: Effect of vasoactive intestinal peptide (VIP) on
carbachol-stimulated ileum.
The cAMP-mediated
agent VIP caused a concentration-dependent
inhibition of carbachol-stimulated ileal motility
with an ED50 = 10-8 M (inset).
This effect was
reversible after cessation of VIP administration,
n = 4 for each group.
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inhibition of CCK
of 15 - 20 seconds
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similarly caused a dose-dependant

(10-9M) -stimulated motility after a latency
(Figure 23).

Motility returned to

previous levels after stopping the VIP infusion.

E

d>

I

E
E

£

_j

1-

o
CCK 10 9 M
VASOACTIVE INTESTINAL PEPTIDE

Figure 23: Effect of vasoactive intestinal peptide (VIP) on
cholecystokinin-stimulated ileum.
The cAMPmediated agent VIP caused a concentration-dependent
inhibition of cholecystokinin-stimulated ileal
motility with an ED50 = 10~8 M (inset).
This effect
was reversible after cessation of VIP
administration,
n = 4 for each group.
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NQREPINEPHRINE INHIBITION
Norepinephrine

(10-8-10-6M)

caused a concentration-

dependent decrease in measure motility in carbacholstimulated ileum

(Figure 24).

The inhibition was reversible

upon the cessation of infusion.
(10~6M)

for five minutes,

norepinephrine

(10-6M) ,

inhibition of motility

CartMChoI

10 *M

10'm

Preinfusion of tetrodotoxin

followed by administration of

failed to reverse norepinephrine's
(Figure 25).

io 8 m

NOREPINEPHRINE

NE 10 6 M

NE OFF

Figure 24: Effect of norepinephrine on carbachol-stimulated
ileal motility.
Norepinephrine caused a complete
but reversible inhibition of carbachol-stimulated
ileal motility,
n = 4 for each group.
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TTX OFF

Figure 25:Effect of pretreatment with tetrodotoxin (10-6 M) on
norepinephrine inhibition of carbachol-stimulated
motor activity.
Tetrodotoxin was preinfused for 3
min prior to the administration of norepinephrine.
Norepinephrine completely but reversibly abolished
measured motor activity in the carbachol-stimulated
preparation,
n = 4 for each group.
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FORSKOLIN INHIBITION
Forskolin

(10-7-10-5M)

similarly caused a concentration-

dependent decrease in measured motility in carbachol
stimulated ileum

(Figure 26).

Like VIP and norepinephrine,

forskolin's inhibitory effect was reversible.

Norepinephrine

appeared to be 10 times more potent in reversing carbachol
stimulated motility than forskolin.
Results of the actions of cAMP dependent agents on
carbachol-stimulated ileal motility is summarized in Table 4.

350 -i

Carbachol

10 7 M

10 7 M

10 6 M

10 5 M

FORSKOLIN

FK 10 5 M

FK OFF

Figure 26: Effect of forskolin on carbachol-stimulated ileal
motility.
Forskolin, a diterpene compound which
increases intracellular cAMP, reversibly inhibited
carbachol-stimulation of phasic contractions.
n =
4 for each group.
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EFFECT OF cAMP-MEDIATING AGENTS ON CARBACHOL-INDUCED

MOTOR ACTIVITY

CARBACHOL
(10-7 M)

312 + 6

★

VIP

NOREPINEPHRINE

(10-8 M)

(10-6 M)

67+11*

42+15*

P < 0.05 COMPARED TO CARBACHOL

FORSKOLIN
(10-5 M)

53+11*

(10"7 M)-STIMULATED MOTOR ACTIVITY
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WHICH

INHIBIT

INTRACELLULAR

CAMP

FORMATION

NPY/PYY REVERSAL
We then attempted to define the role of agents which
inhibit intracellular cAMP formation in intestinal motility.
PYY and NPY had no effect on CCK-stimulated motility

(Table

5).

followed

Preinfusion of PYY

by VIP

(10~8M)

administration,

inhibition of motility
doses of PYY
VIP.

(10-10M)

(Figure 28),

had no effect.

for 5 minutes,

did however reverse VIP's

(Figure 27).

Preinfusion of lower

did not reverse the inhibitory action of

Preinfusion of NPY

activity
9M)

(10-9 - 10-8M)

(10-8M)

also reversed VIP's inhibitory

whereas lower concentrations of NPY

PYY is therefore approximately 10 times

more potent in reversing VIP's actions than NPY

TABLE 5.

EFFECTS OF VIP,

PEPTIDES
CCK IO

-9

(Table 6).

PYY AND NPY ON CCK-STIMULTED MOTILITY

lH—_M

10-hl M

M

CCK 10-9 M + VIP

(10-

1Q^_M

IONIUM

480+52
122±17*

162±14*

455+58

CCK 10-9 M + NPY

598±62

554+58

384+82

CCK 10-9 M + PYY

416+16

518+46

470±42

★

P < 0.05 COMPARED TO CCK

(10~9M)
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PYY 10 9

4
vip io 8

4

4
4

Figure 27: Effect of peptide YY (PYY) on VIP-mediated
inhibition of cholecystokinin-stimulated ileal
motility.
PYY, when pretreated prior to VIP
administration, abolished VIP's inhibition of motor
activity.
A concentration-dependent inhibition of
motility was seen with an ED50 of 3 x 10-10 M
(inset).
This effect was 10 times more potent than
NPY.
n = 4 for each group.
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NEUROPEPTIDE Y

NPY 10 8 4

4
VIP io 8

4

4

Figure 28: Effect of neuropeptide Y (NPY) on VIP-mediated
inhibition of cholecystokinin-stimulated ileal
motility.
NPY, when pretreated prior to VIP
administration, abolished VIP's inhibition of motor
activity.
A concentration-dependent inhibition of
motility was seen with an ED50 of 3 x 10-9 M
(inset),
n = 4 for each group.
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TABLE 6.

EFFECTS OF PYY AND NPY ON VIP MEDIATED INHIBITION OF

CCK STIMULTED MOTILITY

PEPTIDES

10^& M

CCK

10-22. M
475+43

CCK 10-9 m + VIP 10-8 M + NPY

500+17

114+66*

120+60

CCK 10-9 M + VIP 10-8 m + PYY

452+29

476+66

167+51

★

P <

0.05 COMPARED TO CCK

(lO-^M)
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SPECIFIC Y AGONISTS
To determine which Y receptor may be involved in
regulating intestinal motility, various Y receptor agonists
were tested.

When the ileal preparation was pretreated with

the specific Y1 agonist

[Leu31, Pro34]NPY,

motility recordings

were similar to those of NPY/PYY's reversal of VIP mediated
inhibition.

This inhibition of motility was active at the

same concentration range as PYY

(Figure 29).

The ED50 of

[Leu31, Pro34]NPY was 3 x 10"11 M.
The specific Y2 receptor agonist NPY(13-36)

was

similarly added to the preparation prior to the addition of
the motility antagonist VIP.

However, NPY(13-36)

failed to

reverse VIP-mediated inhibition up to concentrations of 10-7 M
(Figure 30).
Similarly,
Y3 receptor,

pancreatic polypeptide, which recognizes the

failed to reverse VIP-mediated inhibition up to

concentration of 10-8M

(Figure 31).

The results of the NPY/PYY/PP receptor analogues are
summarized in Table 7.
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VIP 10'8 M

CCK10'“m

VIP 10"® M

I0'"M

3xI0'"M

io,0m

io“m

LPNPY

LPNPY 107 VIP

VIP OFF

Figure 29: Effect of [Leu^i, Pro34]NPY, (LPNPY), on VIPmediated inhibition of cholecystokinin-stimulated
ileal motility.
LPNPY, when pretreated prior to
VIP administration, abolished VIP's inhibition of
motor activity.
A concentration-dependent
inhibition of motility was seen with an ED50 of 3
10-n m (inset).
n = 4 for each group.
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10 ' M

NPY 13-36

NPY
VIP 10-8
13-36

VIP OFF

10'9

Figure 30: Effect of the long C-terminal fragment of NPY, NPY
13-36, on VIP-mediated inhibition of
cholecystokinin-stimulated ileal motility.
NPY 1336, when pretreated prior to VIP administration,
failed to abolish VIP's inhibition of motor
activity in concentrations as high as 10~7 M.
n =
4 for each group.
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VIP 10* M
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109 M
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10* M

Pancreatic Polypeptide

Figure 31: Effect of pancreatic polypeptide (PP) on VIPmediated inhibition of cholecystokinin-stimulated
ileal motility.
PP, when pretreated prior to VIP
administration, failed to abolish VIP's inhibition
of motor activity in concentrations as high as 10-7
M.
n = 4 for each group.
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AND PANCREATIC POLYPEPTIDE

ON VIP-MEDIATED INHIBITION OF CCK STIMULATED MOTILITY

PEPTIDES

10^5. M

CCK

10-L M

lO^JHM

316+32

CCK 10-9 M + VIP 10-8 M + LPNPY

325±25

307+65

293+61

CCK 10-9 M + VIP 10-8 M + NPY 13-36

94+7*

103+8*

97+11*

CCK 10-9 M + VIP 10-8 M + PP

61+22*

76+10*

84+20*

* P < 0.05 COMPARED TO CCK

(10-9M)
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DISCUSSION
Validation

of

model

The motility patterns derived using this model of gut
motility were similar to those obtained in other isolated
intestinal models and indistinguishable from those seen in
vivo in man

(Fox 1985,

Sarna 1989,

Summers 1983). Viability

of the preparation was confirmed by analyzing oxygen tensions
in the arterial perfusate and venous effluents.

In addition,

hematoxylin and eosin stained sections of ileum after ninety
minutes of perfusion demonstrated viable bowel.

A direct

correlation between intestinal transit time and contractile
activity,

as measured in the present study,

Using this model system,

cannot be made.

one is able to quantitate intestinal

smooth muscle contractility and to investigate its regulation
by gut peptides in an intact model which preserves the
relationship between myenteric plexus and intestinal smooth
muscle.

Prokinetic

Agents

CARBACHOL
The present study demonstrated the prokinetic actions of
carbachol in isolated perfused segments of terminal ileum.
Carbachol,
mechanisms,

an agent which acts through Ca++-dependent
generated a concentration-dependent increase in

ileal motility.
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In this model, we utilized a Ca++ agonist to stimulate
phasic motor activity.

Prokinetic agents produce contraction

in smooth muscle cells by increasing intracellular levels of
Ca++ from stores within the cell

(Makhlouf 1987).

Smooth

muscle contraction is brought about when Mg2+-ATPase activity
of actomyosin is activated in the presense of Ca++.

Cross¬

bridging between actin and myosin chains thus results in
smooth muscle cell contraction

(Hartshorne 1987).

CHOLECYSTOKININ
CCK is a well characterized motility agonist in the
ileum of several species
species involved,

(Amer 1972A,B).

Depending on the

it exerts its prokinetic action by either

acetylcholine release from the myenteric plexus,
neurogenic

(tetrodotoxin sensitive)

a purely

mechanism. Alternatively,

in other species CCK acts via a combination of neurogenic and
direct,

non-neurogenic

(tetrodotoxin-insensitive)

of smooth muscle receptors

stimulation

(Stewart 1977). CCK caused a

concentration-dependent increase in measured motor activity.
In this model,

tetrodotoxin did not inhibit motility and even

resulted in a slight increase in contractile activity. This
suggests that CCK activates rabbit ileal smooth muscle by a
direct stimulation of cell surface receptors.
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MOTILIN
In our study,

motilin was demonstrated to possess

significant prokinetic actions on isolated perfused segments
of rabbit ileum.

Intravenous administration of motilin was

reported to produce contraction of the lower esophageal
sphincter in dog
1977)

(Jennewein 1973)

and dog stomach

(Brown 1971,

and opossum

(Gutierrez

Brown 1972,

Cook 1974).

Motilin has also been shown to increase action potentials of
the antrum and duodenum in dogs

(Wingate 1976).

The primary role of motilin appears to be the
coordination of the migrating myoelectric complex in both the
stomach and duodenum.

Phase III contractile patterns appear

in the duodenum immediately after a similar,
identical pattern,

in the stomach

but not

(Tanaka 1989).

This

observation accounts for the coordination in both duodenal
Phase III activity and gastric phase III activity in
propelling digesta distally through the intestine.

Peaks in

plasma motilin levels have been demonstrated with the
occurence of MMC in the stomach and duodenum
Vantrappen 1979).

In addition,

(Lee 1978,

administration of anti-motilin

antibody resulted in abolished MMC activity in both the
stomach and duodenum.
Motilin appears to act directly on the smooth muscle
cells of the duodenum and cause propagation of the MMC
distally through the small intestine in a calcium-dependent
process

(Adachi 1981).

The effect of motilin

is greatest in

*
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the duodenum where it is reported to be 100 times more potent
than acetylcholine and in addition,

more pronounced in

duodenum than ileum

This further supports the

(Adachi 1981).

concept that the duodenum is an important pacemaker in
regulating intestinal motility.

CAMP

DEPENDENT

AGENTS

In this study we explored the role of cAMP dependent
agents in the regulation of intestinal motility.

We used for

a model carbachol-stimulated motility in isolated perfused
segments of rabbit terminal ileum.
system,

carbachol,

mechanisms,

In this experimental

an agent which acts through Ca++-dependent

generated a concentration-dependent increase in

ileal motility.

Both VIP and norepinephrine are

neurotransmitters which are found in high concentrations in
enteric neurons and increase intracellular levels of cAMP.
These two agents inhibited in a concentration dependent
manner motility stimulated by carbachol.

In addition,

forskolin which also acts through cAMP mediated mechansisms
inhibited carbachol stimulated motility.

Neuronal blockade

with tetrodotoxin failed to block the inhibition of carbachol
stimulated motility by norepinephrine.

VASOACTIVE INTESTINAL PEPTIDE
Vasoactive intestinal peptide

(VIP)

is a

neurotransmitter found within the myenteric and submucosal

'
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plexuses of the gut

(Bitar 1982).

VIP containing neurons

project into the circular muscle layer and run parallel with
the smooth muscle cells.

VIP can hyperpolarize the smooth

muscle cell membrane and relax tension in gastrointestinal
circular muscle

(Bishop 1983, Mahklouf 1982).

In addition,

VIP causes an increase in intracellular levels of cAMP.
These elevated levels of cAMP cause activation of cAMPdependent protein kinases which are involved in smooth muscle
cell relaxation

(Willenbucher 1992).

Indeed,

our results

support previous models since VIP caused a concentrationdependent reversal of carbachol-stimulated phasic
contractions.
VIP's inhibitory action on intestinal motility is well
characterized in the intestinal tract of many species. VIP
neurones project into the muscle layers of the intestinal
wall and are subject to inhibitory tone of opioid neurones.
These in turn are inhibited by somatostatin neurones in the
myenteric plexus. During the descending relaxation phase of
peristalsis,

somatostatin is released and this inhibits the

opioid neurons,

so releasing the restraint on VIP neurones.

As a result VIP is released and smooth muscle relaxation
results.

This relaxation of smooth muscle is accompanied by

an increase in cAMP levels. VIP is also a potent secretogogue
in intestinal mucosa,

its action likewise being mediated by

the second messenger cAMP.

Inhibition of motility

demonstrated in the present study was dose dependent and

*
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reversible after stopping the VIP infusion, when motility
returned to previous levels. These findings point to a
physiological inhibition of smooth muscle contraction.

NOREPINEPHRINE
In the gut,

norepinephrine is found in high

concentrations in postganglionic sympathetic neurons.

It is

thought to act on intramural ganglia of the gut and blood
vessels

(Burks 1987).

Adrenergic fibers which contain

norepinephrine are also known to synapse directly with smooth
muscle cells.

Binding of beta-adrenergic receptors by

norepinephrine activates adenylate cyclase with subsequent
increases in intracellular concentrations of cAMP.
study,

In our

norepinephrine caused a concentration-dependent

decrease in carbachol-stimulated motor activity.

This

observation supports the classical model of tonic opposition
of the parasympathetic system by the sympathetic nervous
system.

FORSKOLIN
Forskolin,
forskohlii,

a diterpene from the roots of Coleus

(Bhatt 1977)

is a known activator of adenylate

cyclase with subsequent activation of cAMP-generating systems
within the cell

(Seamon 1981).

Forskolin does not appear to

activate adenylate cyclase by interaction with cell-surface
receptors

(Seamon 1981) but rather through direct activation

%
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of the catalytic subunit of the adenylate cyclase enzyme
complex

(Rodbell 1980).

As with norepinephrine and VIP,

forskolin caused a concentration-dependent inhibition of
carbachol-stimulated phasic contraction.

These results

suggest that inhibition of motility may be a characteristic
shared by a broad class of agents which stimulate adenylate
cyclase activity.
More than one mechanism may be involved in relaxation of
smooth muscle which is mediated by cAMP.

Among those invoked

is mobilization of Ca++ into intracellular stores and/or
inhibition of the activity of CaWcalmodulin-dependent myosin
light chain kinase

(Hartshorne 1987).

Additionally,

it has

been suggested that cAMP modulates the sensitivity of the
contractile apparatus to existing concentrations of calcium
(Kamm 1989)
hydrolysis

as well as inhibition of phosphoinositol
(Hall 1989,

Kim 1989).

Scheid proposed that cAMP

enhanced Na+/K+ transport and induce relaxation.

Stimulation

of this transport induces relaxation through enhanced Na+/Ca++
exchange

(Scheid 1979).

In conclusion,

this study indicates that regulatory

agents which act through cAMP dependent mechanisms inhibit
carbachol stimulated motility in isolated segments of
terminal ileum and suggests that these agents may play a role
in the counter-regulation of calcium dependent gut motility.
Furthermore,

our results imply that pharmacologic agents

which stimulate adenylate cyclase or lead to increased
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intracellular levels of cAMP may be recruited to subserve
this same role.

These observations may point towards new

avenues for the development of pharmacotherapeutic probes
aimed at the treatment of the many disturbances of
gastrointestinal motility which plaque Western society.

AGENTS

THAT

INHIBIT

INTRACELLULAR

CAMP

FORMATION

PYY AND NPY
PYY is stored in mucosal
colon,

"1" cells,

principally in the

and is released in response to a variety of stimuli

including bile salts and short chain fatty acids.

Blood and

tissue levels of PYY are increased in many diarrheal states
and short bowel syndrome.

In vivo,

PYY inhibits myoelectrical

and peristaltic activity in the small intestine.

Evidence

exists to support the concept that PYY causes a compensatory
slowing of gut motility in rapid transit states such as
celiac disease and short bowel syndrome.

PYY shares 70%

sequence homology with neurotransmitter,

Neuropeptide Y

(NPY).

Both NPY and PYY have essentially the same biological

activities although PYY is more potent in many biological
systems.
rhythm,

Centrally, NPY is involved with control of circadian
memory and food ingestion.

Peripherally,

NPY

potent modulator of gut epithelial ion transport.
findings in Human Erythroleukemic cell Lines
receptor subtypes have been proposed for NPY:

(HEL),

is a

Based on
two

Yx and Y2.

Y2

represents the predominant receptor in the central nervous
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system and is the major presynaptic receptor.

Yi

and Y2

receptors occur in both pre- and post- synaptic locations.
Specific agonists have been synthesised for Y3 and Y2
receptors; The specific agonist at Y4 receptors is the analog
[Leu31, Pro34]NPY,
NPY,

and Y2 agonist is the C-terminal fragment of

NPY(13-36).
In addition,

receptors,
1993).

scientists have recently identified two new

designated Y3 and Y4 (Wahlestedt 1992,

Ballantyne

The Y3 receptor shows affinity for NPY but not PYY.

The Y4 receptor is characterized by having equal affinity for
NPY,

PYY and pancreatic polypeptide.
Several previous studies have described an inhibitory

role of PYY on CCK stimulated gut motility in the rat. This
has been put forward as an explanation of PYY1s slowing
action on gut transit in diarrheal states.
rabbit model,
motility.

neither

In the present

PYY nor NPY inhibited CCK stimulated

In separate studies we were unable to demonstrate

inhibition of carbachol stimulated motility by PYY at
physiological concentrations in the isolated perfused rabbit
model.
The present findings of PYY and NPY’s reversal of VIP
mediated inhibition of intestinal motility indicate that PYY
and NPY may inhibit intestinal transit by abolishing VIP
mediated descending inhibition. The results reported here
indicate that this is mediated by post synaptic

(Y3)
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receptors.

It is of interest that both VIP and CCK

present model)

(in the

also act at a post synaptic location.

In colonic mucosa, VIP-stimulated ion transport is
inhibited by both PYY and NPY. This is due to a lowering of
VIP-stimulated increase in cAMP levels.

In the same isolated

perfused colon model we have previously demonstrated PYYstimulated release of VIP, which may represent an example of
feed-back inhibition of VIP-stimulated mucosal ion transport.
Other studies have demonstrated CCK-stimulated release of VIP
from intestinal mucosa. These studies,

together with the

present findings demonstrate a close resemblance between
regulation of gut secretion and control of gut motility.
Stimulants of mucosal secretion
and conversely,

(VIP)

inhibit gut motility

antagonists of secretion

(PYY and NPY)

reverse VIP's inhibition of motility.
The integration of PYY and NPY's inhibition of VIP into
the current model of gut motility is a new concept.
relaxation

(descending inhibition),

A wave of

mediated by VIP release,

precedes a bolus traveling along the gut. Orad to the bolus,
a wave of contraction

(ascending contraction)

cholinergic neurones.

The present study demonstrates PYY and

NPY inhibit VIP mediated relaxation.

is mediated by

Prevention of descending

relaxation may inhibit the coordinated distal propagation of
gut contents. This provides a mechanism for PYY1s known
action of slowing intestinal transit. Two important points
emerge from the present study;

first the demonstration of the
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parallel control of gut secretion and motility and;

second,

possible mechanism to explain PYY's slowing of intestinal
transit.
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